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Introduction: Non-epileptic seizures (NES) refer to seizures and involuntary 
movements that look like epilepsy but are of unclear aetiology. It has been suggested 
that a range of psychological factors are important in the development of NES. 
Recent research has suggested impaired sleep might be a maintaining factor for 
NES, with some suggesting that sleep may influence seizures via its influence on 
dissociation. Understanding sleep in NES is important because if poor sleep is a key 
feature of NES, then treatments, such as CBT-I, that readily improve sleep in 
physical and mental health problems, may be worthy of trial in NES. I aimed to 
explore whether those with NES experienced more subjective or objective impaired 
sleep, whether this was linked to next day functioning, and if possible, to the 
occurrence of seizures.  
 
Methods: A control group (N = 20) and a NES sample (N=17) completed baseline 
questionnaires on sleep, dissociation, anxiety and depression and provided 
demographic information. Then for 6 consecutive nights wore an Actiwatch activity 
monitor and completed a daily sleep diary and daily measures of mood and 
dissociation. The NES sample was also asked to provide seizure frequency details at 
baseline and daily throughout the study period.  
 
Results: Analysis using independent sample t-tests and multi-level modelling 
suggests that those in the NES group report subjectively and experience objectively 
poorer sleep. No sleep variables from the preceding night’s sleep affected next day 
mood and dissociation or next day seizure frequency. However, the sample was 
underpowered for this analysis. 
 
Conclusion: Preliminary outcomes show that impaired sleep (both objective and 
subjective) is a feature of NES and that this could have clinical implications. 
However, future research with larger samples is required to explore whether sleep 
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Chapter 1. Literature Review  
 
1.1 Non-epileptic seizures (NES) 
In 1878, Professor of Physiology, Arthur Gamgee, published an account in which he 
depicts a case by French neurologist Jean-Martin Charcot, demonstrating what he 
called “Hystero-Epilepsy". In this account, he describes symptoms, specifically 
seizures, that mimic those of epilepsy but were acquired due to mental distress as 
opposed to neurological or organic causes. Gamgee’s account was the first published 
work on what is now commonly known as Non-Epileptic Seizures (NES) and Non-
Epileptic Attach Disorder (NEAD). While there is currently no agreed term to 
describe NES, they have previously also been known as pseudo-seizures, hysterical 
seizures, psychogenic seizures, dissociative convulsions and seizures and are now 
classified in the DMS-5 and ICD-10 as a form of conversion disorder. The 
development of the understanding of NES can be indicated by the terms employed 
to describe this, which initially adopted a stance in which these seizures were 
"pseudo", suggesting that these seizures were not "real" and were perhaps "put on" 
by individuals. This then moved to the understanding of NES in the context of 
mental distress and as a result of "hysteria", which despite having multiple unclear 
definitions, eventually became synonymous with the physical expression of severe 
emotional pain (Whitlock, 1967). Similarly, a more recent understanding of NES is 
that it is a set of movements and sensations, similar to those in epilepsy, believed to 







The most recent developments in theorising the aetiology of NES perhaps take a 
more biopsychosocial view on NES, and take a more monist perspective on mind 
and body (Brown and Reuber, 2016)  Indeed, it has further been said that NES 
“straddle the continuum of neurology to psychiatry, and their presentation blurs the 
margins of these two disciplines” (LaFrance, 2012, p.177).  
 
The main feature of NES is its similar symptomology to epilepsy; in fact, it has been 
suggested that NES accounts for 15-30% of presentations in epilepsy services 
(Bodde et al., 2009). It is thought that currently, there are 15,000 people in the UK 
living with NES (NEAD, 2019); however, difficulties in identifying NES indicate 
that this figure is likely to be higher. Moreover, it is thought that around 2 to 33 in 
100,000 are likely to be affected by NES (Benbadis & Hauser, 2000), suggesting 
that the first figure is a considerable underestimation, further indicating the lack of a 
solid understanding of NES. It is thought that NES is more likely to be developed by 
women and figures suggest that 60- 75% of NES sufferers are women (O’Sullivan, 
2007; McKenzie, Russell, Pelosi & Duncan, 2010).    
 
There is an acknowledgement that NES comes with considerable costs to sufferers, 
their carers and our health systems (LaFrance & Benbadis 2006; Smith, 2014; 
Fitzsimmon, Page & Aram, 2017; Karakis et al., 2014). This suggests that there is a 
real need for a better understanding of the development and maintenance of this 
condition. For this thesis, I have chosen to use the term NES to refer to both NES 







It is both that which is similar, and that which differs that distinguishes NES from 
Epileptic Seizures (ES). It is crucial to be able to differentiate between NES and ES 
as incorrect diagnoses are inappropriate, ineffective, expensive and impact 
significantly on the lives of patients with NES (Krumholz, 1999). Much of the 
research in NES is in comparison to ES, often in an attempt to emphasise the 
psychological or somatic nature of NES, as well as how seizures are subjectively 
experienced in these two seizure conditions. Individuals with NES report more 
frequent and disabling seizures than those with epilepsy (Barry et al., 1998). 
Additionally, individuals with NES also report significantly worse quality of life and 
mood problems (Szaflarski et al., 2003) and perceive their health status to be poorer 
(Al Marzooqi, Baker, Reilly & Salmon, 2004) than individuals with ES. 
Furthermore, it is likely that individuals with NES feel less supported or not 
believed by health professionals as it was found that many clinicians perceive these 
individuals to be able to control their seizures (Iriarte, Parra, Urrestarazu & Kuyk, 
2003). 
 
Many attempts have been made to distinguish between the physical characteristics 
between NES and ES. Gröppel, Kapitany & Baumgartner (2000) analysed EEG 
videos of 27 patients and identified three clusters of NES; clonic and hypermotor 
movements, trembling of the upper and lower extremities and falling on the floor as 
the only symptom. This supports other studies that have distinguished between NES 
and have found that patients with motor manifestations of NES had a history of 
sexual and physical abuse, compared to those with limp or unresponsive 






investigating NES characteristics have suggested that ictal eye closure captured on 
EEG video was a reliable differentiator between NES and epilepsy (Chung, Gerber 
& Kirlin, 2006). However, it was later found that this was only able to accurately 
identify 64% of the cases with NES (Syed et al., 2008). Furthermore, research 
suggests that those with NES are less likely to present with increased heart rate 
during seizures when compares to ES (Oliveira, Gondim, Hogan & Rola 2007). It 
has been found that an increase in heart rate of 30% or more, almost always 
successfully distinguished ES from NES (Opherk & Hirsch, 2002). Despite efforts, 
there are currently no clear set of characteristics or symptoms that can concretely 
and accurately distinguish NES from ES from observation only. 
 
1.2 Development of NES  
The term NES clearly describes that the seizures are not epileptic but is not 
informative about the nature or development of these seizures. The development of 
NES has been debated at length, and I would argue, has a significant impact on if 
and how diagnoses of NES are made, as well as how health professionals engage 
with individuals with NES. The majority of current literature maintains the position 
that NES is likely caused by psychological factors and research commonly prefaces 
NES with the word “psychogenic” (PNES). However, psychological factors are a 
relatively all-compassing term and can include experiences of trauma, mental health 
conditions, interpersonal problems, attachment, alexithymia, family dysfunction and 
stressful life circumstances. Furthermore, all these factors are known to interact, 






of the thesis we will describe research on psychological factors implicated in NES.  
 
1.2.1 Trauma 
One of the most researched possible causes or contributors to NES is trauma. 
Trauma is described as “the unique individual experience of an event or of enduring 
conditions in which the individual’s ability to integrate his or her emotional 
experience is overwhelmed (i.e. his or her ability to stay present, understand what is 
happening, integrate the feelings, and make sense of the experience), or the 
individual experiences (subjectively) a threat to life, bodily integrity, or sanity 
(Pearlman & Saakvitne, 1995, p. 60). There is extensive literature on the impact of 
emotional trauma on our bodies and physical health, however none as influential as 
the Adverse Childhood Experiences (ACE) studies. In these large-scale studies, they 
found that traumatic childhood experiences were significant predictors of health risk 
behaviours and development of poor physical health, including obesity, cancer and 
cardiovascular diseases (Felitti et al., 1998; Anda et al., 2006), even in the absence 
of PTSD (Sledjeski, Speisman & Dierker, 2008). In line with this, much of the 
research in NES suggests that emotional trauma contributes to the development of 
NES (Kuyk et al., 1999). A review of 17 studies observing the link between NES 
and traumatic experiences found that 44-100% of participants with NES reported at 
least one traumatic experience. Furthermore, the population that presents with NES 
are more likely than those with epilepsy to report multiple or ongoing traumatic 
experiences, which are thought to be key in predicting the development of NES 
(Rosenberg et al., 2000), in particular, abuse and neglect are implicated (Proença et 







Additionally, abusive childhood experiences are not unique to NES, and many with 
ES have had such experiences too. However, childhood psychological abuse in NES 
was found to be a notable difference when comparing the groups and was thought to 
be mediated by family dysfunction (Salmon, Al-Marzooqi, Baker & Reilly, 2003). A 
further study investigating the predisposing, precipitating and perpetuating factors of 
NES found primarily trauma, closely followed by bereavement and family 
dysfunction to be significant predisposing and precipitating factors (Reuber, 2007). 
Effectively, it has been argued, in line with some early psychological thinking on the 
matter,  that research into trauma in NES is suggestive of a model in which NES is a 
physical communication of that which could not be or was not allowed to be 
expressed verbally (Quinn, Schofield & Middleton, 2010). This supports findings in 
which those living with NES have rated their family as particularly dysfunctional 
concerning communication (Krawetz et al., 2001).  
 
Although it is widely accepted that there is a high prevalence of trauma in 
individuals with NES (Brown & Reuber, 2016b) and that trauma can even predict 
the development of somatic symptoms (Sansone, Pole, Dakroub & Butler, 2006), the 
majority of people who have experienced trauma do not develop NES. Furthermore, 
a systemic review of the psychological aspects of NES by Brown & Reuber (2016a), 
suggests that the extensive research into trauma in NES does so retrospectively, 
over-represents women, often have small sample and effect sizes and are usually 
conducted in comparison to ES instead of other mental health difficulties. The 






possibly because those with NES are more likely to present in neurology services 
rather than psychiatric services. This suggests that while trauma could be a factor in 
the development of NES, a better understanding is required to distinguish between 
those who do develop NES and those who do not.   
 
There is some evidence to suggest that the development of NES is perhaps linked to 
the processes that change as a result of the trauma as opposed to the traumatic 
experiences themselves. For example, research suggests that those with NES were 
more likely to adopt less effective emotional coping styles such as avoidance and 
were less likely to engage in task-orientated coping techniques such as problem-
solving (Myers, Fleming, Lancman, Perrine & Lancman, 2013). Additionally, 
experiences of interpersonal trauma, such as physical, emotional and sexual abuse, 
can significantly impact on the way individuals perceive and process information 
and threat (Buckley, Blanchard & Neill, 2000). Moreover, Bakvis and colleagues 
(2009) conducted a study using pictorial Stroop Task with 19 individuals with NES 
and a control group of 20. While this was a relatively small sample, they found that 
the participants with NES, who self-reported sexual abuse, indicated significantly 
more hypervigilance than the control group. These findings suggest that a critical 
difference between those who have experienced trauma and further go on to develop 
NES may lie in how their perception and processing of threat is affected.  
 
Whereas the majority of research in trauma in NES focuses on interpersonal and 
developmental trauma, there is evidence that other traumas such as the consequences 






contribute to the development of NES (Moreno & Peel, 2004; Mateen, 2010). 
Although such traumas may be less likely to occur in developing countries, they’re 
often witnessed in refugees and migrants who access care in the western world. In 
Germany, in the height of the political unrest that led to the wave of refugee 
resettlement in Europe, they found that that 20% of refugees attending emergency 
services presented with NES, which is likely to have occurred from trauma such as  
forced displacement rather than cultural differences (Brinckmann, van Noort, 
Leithner & Ploner, 2018).  
 
It may be interesting to note that the majority of research in NES in migrant, 
refugees and other race, ethnic or cultural differentiations consistently use the term 
pseudo-seizures when referring to NES. This is despite the call to avoid this term 
due to the negative implications the word “pseudo” has on both those living with 
and those treating NES (O’Hanlon, Liston & Delanty, N. (2012). It could be thought 
that such research conducted in Western countries, could be mirroring how NES is 
conceptualised in other ethnic and cultural communities. Nonetheless, it raises 
further questions about possible systemic and internalised biases in how clinicians 
and researchers perceive the occurrence of NES in non-Western communities.   
 
1.2.3. Mental Health Difficulties  
There is extensive literature that suggests that those with NES experience higher 
levels of mental health difficulties such as anxiety and depression (Prueter, Schultz‐






stress disorder (PTSD) (Fiszman, Alves-Leon, Nunes, Isabella & Figueira, 2004) 
and dissociative disorders (D’Alessio et al., 2006). Individuals with NES have even 
been found to experience higher levels of anxiety, low mood and hostility when 
compared to those with other somatoform or functional symptoms (Mökleby, 
Blomhoff, Malt, Dahlström, Tauböll & Gjerstad, 2002). There is even some 
evidence to suggest that the combination of depressive and dissociative symptoms 
can predict the development of NES (Mazza et al., 2009), particularly if there has 
been a previous experience of physical or sexual abuse (Scioli-Salter et al., 2016). 
While it is suggested that half of those living with NES have psychological 
comorbidities (Seneviratne, Briggs, Lowenstern & D’Souza, 2011), mental health 
difficulties are often considered a response to traumatic and stressful experiences 
and it is difficult to distinguish between whether mental health difficulties precede 
the development of NES, co-exist as comorbidities or develop as a result of living 
with NES. Additionally, individuals with NES are less likely than those with ES to 
consider psychological factors important in the context of their conditions (Stone, 
Binzer & Sharpe, 2004) and may, therefore, fail to report such experiences.   
 
It is difficult to establish precisely how mental health difficulties can lead to the 
development of NES and perhaps the key to understanding this is to look beyond 
these difficulties into the processes that maintain them. For example, while it has 
continuously been reported that those living with NES experience more emotional 
disorders, there is little understanding about what differentiates between those living 
with emotional disorders who develop NES and those who do not. In recent years, 






emotional disorders such as the implicit and explicit mechanisms of such 
experiences. For example, Dimaro and colleagues (2014) found no differences 
between the levels of implicit and explicit cognitions of anxiety reported by those 
with NES and those with ES. However, they did find that those with NES showed 
more discrepancies between implicit and explicit measures of anxiety, fitting the 
current understanding of the NES profile in that these individuals may experience 
emotions as overwhelming and out of their control (Novakova, Howlett, Baker & 
Reuber, 2015). This is likely to lead to those with NES employing coping strategies 
such as avoidance to escape emotions experienced as overwhelming (Goldstein & 
Mellers, 2006; Frances, Baker & Appleton, 1999). In turn, avoidance has been found 
to correlate with self-reported seizure frequency in NES (Dimaro et al., 2014), 
suggesting that the maladaptive cycle of NES is possibly maintained by avoidance.  
 
1.2.4. Interpersonal Processes & Attachment  
Similarly to trauma and mental health difficulties, interpersonal difficulties or 
diagnoses of personality disorders have been linked to the development and 
maintenance of NES. The prevalence of interpersonal problems in those living with 
NES range from 10% to 86% and are likely to contribute to the difficulties in the 
diagnosis and management of NES (Lacey, Cook & Salzberg, 2007).  There is some 
further evidence that diagnoses of personality disorders were significantly more 
present in those with NES when compared to ES and that this is a better predictor of 
NES development than any other mental health difficulty (Direk, Kulaksizoglu, 
Alpay & Gurses, 2012). This likely to be linked to the interpersonal and 






personality disorders (Silk, Lee & Hill, 1995). These traumatic experiences thought 
to lead to interpersonal difficulties are particularly damaging when they occur 
during childhood (Herman, Perry & Van der Kolk, 1989; Johnson, Cohen, Brown, 
Smailes & Bernstein, 1999; Grover et al., 2007). While it is not unusual for those 
with ES to have experienced interpersonal difficulties as a result of childhood 
traumas (Harden et al., 2009), the nature of these traumas may have further 
implications for the development of NES. For example, in a study that found a 
history of sexual abuse in both NES and ES groups, the NES group were much more 
likely to have had a closer relationship with their perpetrator (Alper, Devinsky, 
Perrine, Vazquez, B., & Luciano, 1993).  It is, therefore, perhaps unsurprising that 
those with NES present with that is considered maladaptive personality traits 
(Reuber, Pukrop, Bauer, Derfuss & Elger, 2004).  
 
In an attempt to better understand the underlying mechanisms of NES, research has 
sought to identify how these link to specific clusters of personality disorders as set 
out by the DMS5 and ICD10. While different diagnoses and processes of personality 
disorders have been linked to somatoform conditions such as NES (Bornstein & 
Gold, 2008), the majority of this research supports that those with NES are most 
likely to present with a borderline process (Hovorka, Nežádal, Herman, Němcová & 
Bajaček, 2007). Some research into interpersonal processes and NES has moved 
away from diagnoses of personality disorders and focused on traits instead. For 
example, it is not unusual to find features of somatisation in those living with NES; 
however, it has been suggested that the combination of traits of somatisation and 






(Bodde et al., 2011; Testa & Brandt, 2010). Those with NES are often also 
perceived to have traits such as care-seeking through sick roles. Contrary to these 
perceptions; however, Testa & Brandt (2010) found that there was no difference in 
the implicit attitudes and beliefs towards illness when comparing their NES group to 
healthy controls. Similarly, other research has focused on the perceptions of 
childhood experiences in those with both NES and borderline processes and found 
that these individuals were more likely to recall lack of parental warmth and regular 
parental rejection (Binzer, Stone & Sharpe, 2004). The evidence outlined above 
makes a good case for the consideration of interpersonal difficulties in the treatment 
of NES (Cragar, Berry, Schmitt & Fakhoury, 2005).  
 
Interpersonal difficulties have been extensively linked to attachment, the symptom 
of the first, often in line with features of the latter (Adshead & Sarkar, 2012). 
Attachment styles could be used to predict the development of interpersonal 
difficulties as it was found that those with secure attachments are less likely to 
develop such problems (Meyer, Pilkonis, Proietti, Heape & Egan, 2001). 
Bartholomew & Horowitz (1991) best explain adult attachments using their four 
category-model, which defines the types of attachment as the following: 
 
- Secure: High self-worth, comfortable with autonomy, and forming close 
relationships.   







- Dismissing: Overt high self-worth, denial of distress and importance of 
relationships.  
- Fearful: Negative self-view, distrust of others, high distress and 
apprehension of close relationships.  
 
A secure attachment infers that while growing up, an individual had caregivers that 
were emotionally available and able to regulate their own as well as the child's 
emotions (Sable, 2008). Insecure attachments, however, suggest that such emotional 
availability was lacking and are linked to experiences of childhood adversity 
including poor support and low self-esteem, which in turn mediate future mental 
health difficulties (Bifulco, Moran, Ball & Lillie, 2002). It therefore stands to reason 
that attachment styles would be an important field to explore in the development of 
NES.   
 
A recent study found that while there was comparatively little difference between 
the attachment styles of those with NES and ES, that the attachment of the first is 
much more likely to be linked to mental health difficulties when compared to those 
with latter (Green, Norman & Reuber, 2017). Other studies focusing on specific 
attachment styles suggest that in particular, fearful-avoidant attachment styles 
prominent in those with NES (Holman, Kirkby, Duncan & Brown, 2008; Lally, 
Spence, McCusker, Craig & Morrow, 2010; Reis & Grenyer, 2004). That being said, 
attachment styles are linked to a range of mental health difficulties, traumatic 
experiences and maladaptive coping techniques, indicating the problem in 







The inability to recognise, describe and express emotions and emotional experiences 
is also known as alexithymia (Sifneos, 1973) and a common suggestion about NES 
and other functional symptoms is that it develops out of the lack or inability to 
express emotional experiences (Reuber, House, Pukrop, Bauer & Elger, 2003; 
Quinn, Schofield & Middleton, 2010).  Moreover, the term conversion disorders 
indicate that these are conditions in which psychological distress is converted to or 
manifests as physical symptoms. This is not a new concept, in fact, Freud first used 
to term conversion disorder precisely to describe such a process in which that which 
was too painful to be acknowledged or felt consciously, would present itself 
unconsciously through the body (Blitzstein, 2008). This psychodynamic 
conceptualisation of NES further suggests that this happens through the 
development of defensives such as denial and repression (Jawad et al., 1995).  
 
It is, therefore, unsurprising that the relationship between alexithymia and NES has 
warranted research. There are conflicting findings for the prevalence of alexithymia 
in NES; a small study comparing alexithymia in NES with those with epilepsy and a 
control group found that 90.5 % individuals with NES met the criteria for 
alexithymia (Bewley, Murphy, Mallows & Baker, 2005). Others, however, have 
found this prevalence to be much lower (25.5%), but suggest that the alexithymia 
alongside other emotional regulation difficulties could be used to distinguish 
between types of NES, which in turn could guide treatment (Brown et al., 2013).  
Additional research has found alexithymia to be particularly important in self-






2014), further suggesting that an inability to express emotional experiences, may 
lead to higher prevalence of somatisation. That being said, it is thought that 
alexithymia found in those with NES was likely to be a result of trauma, further 
providing evidence for the link between trauma and NES (Myers, Matzner, 
Lancman, Merrine & Lancman, 2013). Nevertheless, alexithymia is not unique to 
somatoform conditions and has been considered a predisposing factor in a variety of 
mental health difficulties, including eating disorders and substance misuse 
(Salminen, Saarijärvi & Äärelä, 1995). Furthermore, the inability to recognise and 
express emotional stimuli is often an aspect of common mental health difficulties, 
making it difficult to distinguish whether alexithymia is a preceding or a separate 
co-occurring factor (Berthoz, Consoli, Perez-Diaz & Jouvent, 1999).  
 
1.2.6 Family Dysfunction 
Family dysfunction has been linked to the many variables discussed in this literature 
review and is known to be a feature in depression, (Miller et al., 1992); attachment 
difficulties (Shaw & Vondra, 1993); interpersonal difficulties (Carr & Francis, 2009) 
and alexithymia (Mallinckrodt, King & Coble, 1998). Moreover, many indicators of 
family dysfunction such as neglect, and interfamily sexual abuse are considered also 
considered to be traumatic experiences in their own right. The complexity of 
traumatic experiences in the context of family dysfunction may be particularly 
important when considering how distress is expressed and is likely to lead to the 
“unspeakableness”, which in turn provides an explanation for how somatisation may 







However, “unspeakable dilemmas” may also contribute to the development and 
maintenance of family dysfunction (Betts & Boden, 1992). A study analysing taped 
clinical interview of 14 adolescents and adults with NES and their families found 
that in 13 out of the 14 interviews, there appeared to be evidence of a “unspeakable 
dilemma” (Griffith, Polles & Griffith 1998). The authors further found this dilemma 
was most likely to be concerned with person with NES or their direct family 
member, that the person with NES was the most silent in these interviews and that 
they had managed to effectively conceal their distress from their families by way of 
suppression.  
 
This might explain why people with NES are more likely to perceive their families 
as not committed or as unsupportive to each other when compared to control and ES 
groups (Moore, Baker, McDade, Chadwick & Brown, 1994). These authors also 
report that NES participants were more likely to perceive their families of being less 
concerned with ethical or moral values. Furthermore, family stressors such as illness 
within the family and having a carer’s role has been found to an important 
maintenance factor for NES (Reuber, 2007). It could therefore be further theorised 
that the somatisation of psychological distress that arises from having a carer's role, 
may be a critical factor in the maintenance of seizure occurrence for individuals with 
NES.  
 
1.2.7 Stressful life circumstances  
There is some evidence that individuals with NES are much more likely to have 






compared to both the general public and those living with ES (Tojek, Lumley, 
Barkley, Mahr & Thomas, 2000). The same study found that as those with NES 
were more likely to receive a diagnosis in adulthood and have a family member with 
ES and that this could have contributed to the development of NES as a way to cope. 
Similarly, an earlier study suggested that NES could be seen as a pattern learned to 
cope with stressful experiences (Ramani, Quesney, Olson & Gumnit, 1980). 
 
However, there is an alternative argument, suggesting that those with NES consider 
their general ongoing lives more stressful when compared to both the general 
population and those living with epilepsy (Frances, Baker & Appleton, 1999). 
Effectively, it is argued that those with NES do not objectively experience more 
severe stressors, but rather that they experience these stressors as more distressing 
and are less able to adopt helpful coping strategies (Testa, Krauss, Lesser & Brandt, 
2012). That being said, individuals with NES are less likely to report stressful life 
experiences (Stone, Binzer & Sharpe, 2004), which could be explained by findings 
that those with NES are much more likely to adopt avoidant coping styles in 
stressful situations (Goldstein & Meller, 2006) and when faced with social threats 
(Bakvis, Spinhoven, Zitman & Roelofs, 2011). Perhaps it could be said that stressful 
experiences in which expression of this could be deemed particularly difficult, such 
as family dysfunction, could lead to the expression of distress in another way, i.e. 
somatisation. Furthermore, it has been suggested that individuals with NES adopt an 
external locus of control in the context of their health (Goldstein, Drew, Mellers, 
Mitchell-O’Malley & Oakley, 2000), further indicating that factors perceived as 






reporting of stressors may also imply resistance to psychological or circumstantial 
explanations of what is experienced as a physical condition and be linked to a desire 
for physical symptoms to be taken more seriously by health professionals.  
 
1.2.6 Non-psychogenic explanations  
So far we have concentrated on psychogenic or psycho-social explanations for NES 
and associated variables. However, NES are considered a medically unexplained 
symptom (Weiland et al., 2012) and therefore, an emphasis has been placed on 
psychological factors in the development and maintenance of NES, often 
overshadowing other possible causes. While it is theorised that the development of 
NES does not develop in the same neurological manner that can be observed in ES, 
this does not exclude other non-psychogenic contributions to the development of 
NES. It has been found that 24-32% of individuals with NES reported a history of a 
brain injury prior to developing this condition (Barry et al., 1998; Westbrook, 
Devinsky & Geocadin, 1998). There have also been cases in which individuals with 
NES have been found to present with some abnormalities in-between seizures 
during EGG screenings (de Timary et al., 2002). Further findings suggest that 
organic brain disorder markers are not uncommon in NES (Reuber, Fernandez, 
Helmstaedter, Qurishi & Elger, 2002; Ding et al., 2013; Arthuis, Micoulaud-Franchi, 
Bartolomei, McGonigal & Guedj, 2015).  
 
Other neurodevelopment factors such as intellectual disability (ID) continue to 






of ID in NES is comparable with to that of ES (Kanemoto, Goji, Tadokoro, Kato & 
Oshima, 2017). However, ID in ES has been researched at length, including 
prevalence (McGrother et al., 2006), the impact of living with this dual diagnosis 
(Bowley & Kerr, 2000) and gene expressions (Lemke et al., 2014). Furthermore, 
there is limited research into the neuropsychological profiles of those living with 
NES, but findings suggest that whilst women with NES do not meet the criteria for 
ID, their neuropsychological outcomes suggested working memory and attention 
impaired when compared to those with ES (Strutt, Hill, Scott, Uber-Zak & Fogel, 
2011). Other studies however, that have found that a poor working memory in those 
with NES was likely to be linked reported incidents of abuse (Williamson, Holsman, 
Chaytor, Miller & Drane, 2012). Additionally, I have been unable to find any studies 
specific to the occurrence of NES in those living with autism, despite there being 
much research into the co-occurrence of ES in autism (Gillberg, 1991; Canitano, 
2007; Tuchman, Cuccaro & Alessandri, 2010). While this is likely to be a reflection 
of a lack of a congruent understanding of NES both in clinics and in research, it 
indicates an important gap in the literature.  
 
Non-neurological physical conditions have also been linked to NES; for example, 
asthma and gastro-oesophageal reflux disease were both found to be predictors of 
NES (Elliott & Charyton, 2014). That being said, physical conditions themselves 
could be psychogenic (De Wet, Mellers, Gardner & Toone, 2003). Additionally, if 
adverse childhood experiences are thought to predisposition individuals to the 
development of physical conditions (Felitti et al., 1998; Anda et al., 2006), then the 






Furthermore, many people with neurological and other physical conditions also 
experience mood and functioning impairments, yet unlike with NES, little attention 
is paid to whether such impairments preceded the development of these conditions. 
This may indicate that healthcare continues to hold a dualistic view off wellbeing in 
which we appear to value physical conditions more as their measurability enable us 
to view it as more accurate.  
 
It is worth noting that there are many neurological symptoms and conditions of 
which we have little knowledge about how they are caused and the factors that 
contribute to their development. However, none have received as much attention as 
NES in discounting it as a neurological condition. While there may be many reasons 
why there is such an interest in how NES develops, such as the ability to distinguish 
this from ES, it is clear that psychogenic explanations for this condition are 
favoured, despite the lack of clear cause-and-effect evidence. Disbelief from health 
professionals in patient’s ability to control NES (Iriarte et al., 2003) may also 
contribute to the lack of willingness to investigate non-psychogenic pathways to the 
development of NES. Nonetheless, this raises questions about the possibility of 
neurological or organic causes of NES that have either received little interest or have 
been discounted.  
 
1.2.7. Biopsychosocial explanations  
One of the most researched aspects of NES is in relation to dissociation, which is 






individuals experience their self, their ability to access their memories and 
knowledge, and how they might behave (Putnam, 1994). The International 
Classification of Diseases (ICD-10)1 defines dissociation as “. . . a partial or 
complete loss of the normal integration between memories of the past, awareness of 
identity and immediate sensations, and control of body movements” (p 151). Firstly, 
a distinction must be made between dissociation as a state or a symptom and 
dissociative disorders (DID). The DMS-5 (2013) and ICD-10 (2016) list the 
following dissociative disorders: 
 
- Dissociative identity disorder (DID)  
- Dissociative amnesia including Dissociative Fugue  
- Depersonalisation/Derealisation Disorder  
- Other Specified Dissociative Disorder  
- Unspecified Dissociative Disorder 
 
Furthermore, Dissociative Disorders of Movement or Sensation come under 
Functional Neurological Symptom Disorders (FND) section in the DSM 5, while the 
ICD-10 lists it alongside the other dissociative disorders (Black & Grant, 2014; 
World Health Organisation, 2014). Dissociation is identified by ruling out epilepsy 
and other organic or neurological conditions (DSM-IV, 1994). 
 
There are five core symptoms that dissociative disorders are based on; amnesia, 
depersonalisation, derealisation, identify confusion and identify alternation 






symptoms and dissociation as a state, in particular amnesia, depersonalisation and 
derealisation.  This is because our study aims to look at whether there is a 
relationship between sleep and dissociation in the context of seizure frequency, 
rather than investigating the occurrence of DID in seizure disorders. 
 
Dissociation has been extensively and significantly linked mood impairment, 
psychiatric diagnosis and to the prevalence of traumatic experiences (Coons, 
Bowman, Pellow & Schneider, 1989: Banyard, Williams & Siegel, 2001). However, 
there is some suggestion that traumatic experiences on their own do not predict 
dissociation unless this occurs alongside experiences of post-traumatic stress and 
emotional dysregulation (Briere, 2006). Other theories have linked dissociation to 
proneness to fantasies, suggestibility of memories and cognitive failures such as 
distractibility (Giesbrecht, Lynn, Lilienfeld & Merckelbach, 2008). In this context, 
dissociation appears to be linked more to unusual sleep experiences such as 
nightmares and vivid dreaming rather than impaired sleep (Koffel & Watson, 2009). 
Van der Kloet, Merckelbach, Giesbrecht & Lynn (2012) reviewed the literature on 
the relationship between sleep and dissociation and argued that dissociation emerges 
from disturbed sleep. They propose that dissociation is caused by sensitive sleep-
wake cycles, in which dream-like activity mediates memory failure, which in turn 
increases dissociative experiences. They further propose that improved sleep can 







1.2.8. Dissociation in NES 
Dissociation is considered to be essential to the process of NES (Williams et al., 
1993).  Moreover, NES are often described as dissociative seizures both in research 
and clinically (Wood, McDaniel & Burchfiel, 1998; Meller, 2005). Van der Kruijs 
and colleagues (2011) conducted a neuroimaging study, in which they found that 
both NES and dissociation implicated parts of the brain responsible for voluntary 
muscle movement (precentral sulcus) and emotion regulation, visceral sensory 
perception and self-awareness (insula). They further found that subjective measures 
of levels of dissociation collaborated these findings and that those with NES 
experienced more dissociation when compared to a healthy control group.   
 
However, conceptualising NES as dissociative seizures would suggest that 
dissociation is a process exclusively found in NES, therefore not accounting for the 
findings that dissociation has also been extensively linked with ES (Alper et al., 
1997) and other organic conditions (Good, 1993). Furthermore, the other terms 
describing NES are also indicative of causation, of which there is yet to be a clear 
understanding of. Therefore, it may be more appropriate to use the term NES in 
research investigation dissociation across the seizure disorders. Furthermore, there is 
some evidence that although dissociation is a mechanism in both NES and epilepsy, 
different kinds of dissociative experiences are involved in different seizures. Alper 
and colleagues (1997) used the Dissociative Experience Scale (DES) to investigate 
the difference in dissociation between NES and epilepsy. The DES categorises 
dissociative experiences into the following six domains; depersonalisation, 






(Bernstein & Putnam, 1986). They found that those with NES experienced 
dissociation in the form of depersonalisation and derealisation, whereas those with 
epilepsy experienced dissociation in the form of amnesia, but that both groups 
experienced much more dissociation than the non-clinical population. Interestingly, 
depersonalisation and derealisation are also the dissociative aspects most likely to be 
implicated in the development of depression and panic (Soffer-Dudek, 2014). If it 
was possible to distinguish between the dissociation experiences in NES when 
compared to that of epilepsy, this could be a useful tool in the ‘positive’ diagnosis of 
NES rather than ruling out known neurological conditions.  
 
1.3 Diagnosis of NES 
Appropriate and correct diagnosis of NES is important so that individuals are not 
wrongly treated for epilepsy and has been found to drastically reduce A&E 
attendance and hospital admissions (Razvi, Mulhern & Duncan, 2012). Diagnosis is 
further essential so that if there are underlying psychological difficulties, that these 
can be addressed (Reuber & Elger, 2003). Particularly as it has been suggested that 
individuals with NES present with significantly more interpersonal problems 
(Galimberti et al., 2003); decreased mood and quality of life (Szaflarski et al., 2003) 
and sleep disturbances (Graham & Kyle, 2017) than those with epilepsy.  However, 
diagnosis is not straightforward as NES is not identified using theory, but rather by 
ruling out physical conditions and causes (Brown & Reuber, 2016). As it is thought 
that NES may be considered an individual’s attempt to express psychological 






Bauer & Elger, 2003), diagnosis is also likely to include some exploration of current 
or historical psychological distress.  
 
Diagnosis of NES is made by process of elimination in which other neurological 
causes and conditions are ruled out, alongside other symptoms unique to (ES), such 
as tongue biting and incontinence (de Timary et al., 2002). The use of ECGs to 
diagnose NES is both expensive and uncommon, and differential techniques are 
required to identify NES accurately. However, a review assessing the likelihood of 
diagnosis via means of "demographic and medical history variables, seizure 
semiology, provocative testing, prolactin levels, single photon emission computed 
tomography, psychological testing, and neuropsychological testing” has found 
these means may only be useful as an additional tool to ECG (Cragar et al., 2002). 
The practice of diagnosing NES is further complicated by how clinicians and 
patients experience the communication of this diagnosis. It takes years for a correct 
diagnosis of NES to be made, and many patients have been incorrectly initially 
diagnosed with epilepsy and treated inappropriately with anti-epileptic medication 
(Reuber et al., 2002).  
 
As there is significant research to indicate that different types of traumas might be 
essential in the development of NES, it is vital to think about an individual's life 
history when suspecting NES (Brown & Trimble, 2000). However, most patients 
with NES see neurologists when presenting with seizures that they may believe to be 
epileptic and professionals without a psychological background may not be best 






responses to talking about trauma. Additionally, once a diagnosis of NES has been 
given, clinicians, often neurologists, then have to navigate sharing what is 
considered to be a psychological diagnosis with patients who present with physical 
symptoms and may have already been misdiagnosed with a medical condition. This 
may then be experienced by patients as not being believed to have “real” seizures, 
which for some mimicked the experience of not being believed when disclosing 
abuse as children, suggesting that if not conducted carefully, diagnosis could be 
experienced as traumatising (Prigatano, Stonnington & Fisher, 2002) 
 
Thomson and colleagues (2009) interviewed patients who had recently been 
diagnosed with NES and found the emotional impact of the diagnosis to range from 
relief to anger. They found that patients who experienced relief reported that this 
was because their condition was now known and that their seizures were not as a 
result of something more sinister. Patients who experienced anger reported feeling 
irate at previous misdiagnoses as well as at the individuals responsible for their 
traumatic experiences, as their NES diagnosis was communicated by explaining 
NES as a possible response to trauma. Furthermore, reactions to the communication 
of diagnosis of NES is considered to indicate prognosis, as it has been suggested that 
maintenance of seizure occurrence following diagnosis was linked to reactions of 
confusion or anger, while a reduction of seizure occurrence was linked to reactions 
of relief (Carton, Thompson & Duncan, 2003).  
 
When using a protocol that included a detailed verbal and written information about 






and 63% reported that their seizure-frequency reduced by >50% (Hall-Patch et al., 
2009). However, individuals with NES continue to be confused about their diagnosis 
and its relevance to their experiences of the condition (Green, Payne & Barnitt, 
2004). Similarly, hospital admissions remain high in the NES population, even when 
NES was considered to be resolved (Ettinger, Devinsky, Weisbrot, Ramakrishna & 
Goyal, 1999). Ongoing somatisation of emotional difficulties in the absence of 
seizures is a further indication that treatment needs to go beyond seizure reduction.  
 
1.4. Treatment of NES 
Currently, there is no agreed standard treatment of NES as we lack in-depth 
knowledge as well as data from powered-RCTs (Smith, 2014). A survey of 130 
health professionals who work with NES in the UK, 93% cited psychological 
intervention as their treatment of choice (Mayor, Smith & Reuber, 2011). Similarly, 
psychological interventions have received the most empirical interest. The highest 
quality study to date was a pilot RCT comparing CBT with and without standardised 
medical care (SMC) (N=33) with SMC alone (N=31) with findings that suggested 
that CBT together with SMC was most effective in reducing seizures (Goldstein et 
al., 2010). Indeed, other methodologically limited, smaller or uncontrolled studies 
suggest that psychotherapies could be helpful.  Kuyk and colleagues (2008) 
investigated an open inpatient treatment for NES, which consisted of individual 
psychotherapy, psychomotor and creative therapy, family therapy and participation 
in group therapies for seven months. They found that seizure frequency decreased 
significantly, followed by improved measures of mood, dissociation and ability to 






treatment was effective in complete seizure cessation by the last session in 11 out of 
17 participants that completed the treatment (LaFrance et al., 2009).  Other studies 
have shown that psychodynamic therapy has lasting improvements as at an average 
follow-up period of 42 months found 25.5% of participants were seizure-free, and a 
further 40.4% reported >50% improvement in seizures. (Mayor, Howlett, 
Grünewald, & Reuber, 2010).  
 
There is also some limited, but promising research suggesting the potential for the 
inclusion of EDMR in the psychological treatment of NES (Kelley & Benbadis, 
2007). Additionally, it was also suggested that a brief 4-session psychoeducation 
was could be effective in seizure cessation in some individuals with NES (Wiseman, 
Mousa, Howlett & Reuber, 2016). Nonetheless, it is worth noting that because 
individuals with NES seek treatment for physical symptoms as opposed to 
psychological difficulties, they may not be agreeable to psychological interventions. 
There is also a lack of guidance in terms of what NES treatment and whether this 
needs to be directed at seizure reduction or at the suspected underlying experiences 
and emotions that may have contributed to the development of NES.  
 
1.5. Sleep 
Since Aristotle first developed his ideas on sleep and dreams some 2000 years ago 
(Gallop, 1990), the function of sleep has continued to be investigated and theorised 
and is considered to be a complex process that we have yet to fully understand 






good health (Alvarez & Ayas, 2004) while poor sleep is associated with impaired 
health (Gallicchio & Kalesan, 2009). Although the amount of sleep is an essential 
factor, it has also been argued that the quality of sleep is better related to overall 
wellbeing rather than how long someone has slept (Pilcher, Ginter & Sadowsky, 
1997). Furthermore, individuals who felt satisfied with the sleep they experienced 
also reported better overall wellbeing and quality of life (Jean-Louis, Kripke & 
Ancoli-Israel, 2000), however, we are unable to draw causal conclusions from these 
results.   
 
Considering how much of an impact impaired wellbeing and reduced quality of life 
can have on day-to-day functioning, improvement of sleep should be imperative. 
While sleep deprivation has been known to impact on cognitive and motor 
functioning significantly, it was found that perhaps the most significant impact was 
on mood (Pilcher & Huffcutt, 1996). Sleep deprivation impairs an individual's 
ability to regulate their emotions and leads to an increase in negative cognitive bias 
while reducing the ability to concentrate on non-negative events and experiences 
(Gobin et al., 2015). This implies that the lack of sleep can reduce people's abilities 
to cope as they may be unable to use coping strategies such as distraction if they are 
prone to concentrate on negative events and experiences. 
 
Additionally, a systematic review found that sleep deprivation did not only lead to 
decreased ability to express emotions but also impaired the ability to recognise 
emotions in others, crucial for creating and maintaining social interactions (Beattie 






could be a factor in interpersonal conflicts and relationship difficulties.  Sleep 
deprivation is not only known to be a factor in the development of mental health 
difficulties, but there is also evidence that sleep deprivation continues to be a factor 
in the maintenance of mental health difficulties (Wehr, Sack & Rosenthal, 1987). 
Furthermore, impaired sleep impacts our ability to make any decision (Harrison & 
Horne, 2000), which has a wide-ranging impact on daily functioning.  
 
Sleep difficulties have been extensively investigated in chronic health conditions 
(Davidson et al., 2002; Russell, Wearden, Fairclough, Emsley & Kyle, 2016), 
mental health difficulties (Tsuno, Besset & Ritchie, 2005; Lamarche & De Koninck, 
2007) and substance misuse (Stein & Friedmann, 2006; Brower & Perron,2010). 
While there has been a considerable amount of research into the impact of impaired 
sleep, much of this is based on subjective measures. It is well known that individuals 
who consider themselves to have impaired sleep, report less sleep subjectively than 
is captured by objective measures such as actigraphy (Van De Berg et al., 2008). 
However, if individuals perceive their sleep to have been disturbed, or in some way 
unsatisfying, this could also be a factor for incorrect subjective measures of sleep. 
Given this, studies investigating sleep should do so using both subjective and 
objective measures such as Actigraphy; the data produced by activity monitors, 
often worn on the wrists or waist, which measure movement and estimate sleep for 
periods with little or no movement. 
 
While a considerable amount of research is focused on whether sleep is affected by 






it was found that impaired sleep may contribute to the development of conditions 
such as Type 2 Diabetes (Kawakami, Takatsuka & Shimizu, 2004; Cappuccio et al., 
2010a), particularly as impaired sleep impacts on the metabolic processes in a way 
that makes individuals vulnerable to the development of Type 2 Diabetes (Knutson 
et al., 2007).  In a systematic review about the link between sleep and mortality, it 
was found that long durations of sleep were predictors of death in the prospective 
population, in the same way, that short durations of sleep might be (Cappuccio et al., 
2010b). 
 
Impaired sleep can be caused by factors that interrupt the circadian rhythm that 
manages our body clock in terms of sleep and wakefulness throughout the day (Cole 
& Richards, 2007). A commonly occurring factor in circadian rhythm disruption is 
perceived stress (Treharne et al., 2007).  Particularly stress associated with events or 
expectations of the following day, which has been shown to lead to a shorter period 
of sleep, as well as fragmented sleep (Âkerstedt, 2006).  There is some indication 
that this is especially the case for individuals with a reduced ability to cope with or 
manage their stress, which would suggest that learning coping or management skills 
may lead to improved sleep (Sadeh, Keinan & Daon, 2004). This implies that health 
conditions, including emotional and cognitive difficulties, may impact on sleep 
through stress. Furthermore, impaired sleep in itself can increase cortisol levels the 
following day, alongside a reduced resilience to deal with stress (Leproult, 
Copinschi, Buxton & Van Cauter 2007). This is suggestive of a cycle in which stress 
is a contributor to impaired sleep, a consequence of sleep impairment and a 






Much of the research in sleep focused on impaired sleep in the context of sleep 
deprivation and disturbances, however, it is important to note that excessive sleep 
has also been known to impact on overall wellbeing (Ohayon, Reynolds & 
Dauvilliers, 2013; Jennum, Ibsen, Avlund, & Kjellberg, 2014). Additionally, 
excessive sleep has been extensively linked to diagnoses of mood disorders and 
severe emotional distress (Billiard, Molenc, Aldaz, Ondze, Besset, 1994; Soehner, 
Kaplan & Harvey, 2013). In fact, Hypersomnia is noted alongside Insomnia in the 
DSM5 under Sleep-Wake Disorders, further indicating that excessive sleep may be 
linked to impaired functioning. That being said however, Hypersomnia has been 
used inconsistently by research to describe excessiveness of various sleep domains 
and there is some discussion around whether Hypersomnia should be further 
distinguished between how long people spend in bed and how long they are actually 
asleep (Kaplan & Harvey, 2009).  
 
1.5.1 Sleep Treatment 
The NICE Guidelines (2015) recommends sleep hygiene, hypnotic medication and 
cognitive and behavioural interventions for short-term and long-term insomnia. 
Sleep hygiene in this context refers to advice about lifestyle changes such as 
exercise, the limitation of caffeine intake and fixed times for sleep. Whilst there is 
little support for the effectiveness of sleep hygiene on by itself, it’s considered an 
important part of tackling insomnia (Falloon, Arroll, Elley & Fernando, 2011). 
Instead, Cognitive Behavioural Therapy for Insomnia (CBT-I) appears to be the 
most effective and well-researched intervention for insomnia. CBT-I consists of 5 






and relaxation training (Morin & Benca, 2012) and can be effectively delivered as 
self-help on paper and electronically (Rybarczyk, Mack, Harris & Stepanski, 
2011).CBT-I has been found to improve sleep in individuals with insomnia 
(Okajima, Komada & Inoue, 2011), individuals with both insomnia and psychiatric 
comorbidities (Taylor & Pruiksma, 2014) and those with chronic conditions such as 
cancer (Fleming, Randell, Harvey & Espie, 2014). There is also evidence of 
improved mood and quality of life when CBT-I is used to treat disturbed sleep in 
neuropsychiatric and chronic conditions (Hingray, Biberon, El-Hage & de Toffol 
2016). Furthermore, CBT-I has been found to significantly improve experiences of 
pain intensity and catastrophising, fatigue when treating fibromyalgia (Lami et al., 
2016), a condition characterised by high levels of somatisation (Wolfe & Hawley, 
1998). 
 
1.5.2 Sleep in NES 
Sleep in NES is an understudied field (Pavlova, Allen & Dworetzky, 2015) despite 
evidence that those experiencing seizures suffer from disturbed sleep (Bazil, 2003). 
If ES are known to be linked to impaired sleep and the improvement of sleep known 
to impact favourable on seizure control (van Golde, Gutter & de Weerd, 2011), it 
stands to reason that this may be applied to NES. Indeed, for psychogenic 
explanation of NES, poor sleep could be a cause of the emotion regulation 
difficulties that appear in NES or could reflect the impact of traumatic experiences 
interfering with sleep, like with PTSD. Given the key role of sleep in all possible 






psychogenic and biological explanations of NES), several research groups have 
begun to research sleep in NES.  
 
Bazil, Legros & Kenny (2003) conducted a small comparison study of sleep 
between epilepsy (N=10) and NES (N=8) and found that sleep was experienced 
comparatively in both groups. They did, however, find that participants with NES 
had significantly more REM sleep, similar to those with mood disorders, and 
theorise that this may have been mediated by comorbidities of depression in the 
NES group. If this is true, then it could be further hypothesised that interventions 
that are known to improve sleep disturbances in those with depression, such as CBT-
I (Manber et al., 2008), may prove useful in treating impaired sleep in NES.   
 
Graham & Kyle (2017) measured sleep and functional impairment in a clinical 
sample (N=20) alongside an online sample (N=205) with FND. They found that 
impaired sleep was a key feature in functional impairment the following day and 
that this was independent of depression despite previous suggestions that poor sleep 
in NES is mediated by depression (Bazil, Legros & Kenny, 2003). Sleep in NES 
appears to have gathered more interest in the two years since our research idea was 
first developed and current literature acknowledges that sleep complaints are a 
significant problem for those living with NES (Erickson et al., 2019). Recently a 
study measuring objective experiences of sleep in individuals with NES and 
epilepsy using Polysomnography (PSG) found that both groups experience similar 
sleeping patterns, in particular, late onset of sleep, but that those with NES presented 






2018). Another recent study showed that those with NES were more likely to 
subjective experience greater sleep latency when compared to those with NES 
(Latreille, Dworetzky, Baslet & Pavlova, 2019). However, this same research team 
reported in an earlier paper than generally those with NES were more likely to report 
more severe sleep disturbances subjectively (Latreille, Baslet, Sarkis, Pavlova & 
Dworetzky, 2018). That being said, Latreille and colleagues (2018) note that 46% of 
their NES participants carried a diagnosis of a sleep disorder, compared to 30% in 
the epilepsy group. They further also noted significantly more use of anti-
depressants in the NES group, which are likely to contribute to disturbed sleep 
(Wilson & Argyropoulos, 2005). 
 
1.6. Summary of Literature Review 
To summarise our literature review, research in NES suggests that a wide range of 
variables can contribute to the development and maintenance of the condition. Much 
of the research has focused on how trauma, mental health conditions, interpersonal 
problems, attachment, alexithymia, family dysfunction and stressful life 
circumstances are linked to NES. However, there is limited literature that has aimed 
to pull this research together to provide a coherent and biopsychosocial 
understanding of the factors involved in NES. 
 
One such attempt is a systemic review by Brown & Reuber (2016), in which they 
gathered theorised variables of the development of NES and categorised this into 
four models of process; NES as a dissociative phenomenon, NES as serving a 






and NES as a possible consequence of impaired cognitive function. This model 
suggests that all the variables mentioned above could be considered as potential 
biopsychosocial pathways for the development of NES. Furthermore, the authors 
acknowledge that the variables contributed to each of these models may overlap and 
that this is not an exhaustive list of known causations, but rather an attempt to 
categorise and review the most commonly researched ideas. However, as suggested 
in this literature review at several points, the variables thought to be important in the 


















Chapter 2. Rationale 
To demonstrate that impaired sleep could be considered a common factor 
irrespective of how the development of NES is theorised, we have deliberately 
adopted a dualistic approach in reviewing the research in NES, which is depicted in 
Figure 1. We hope that this will show that because impaired sleep has been linked 
extensively to all the suspected caused of NES, that sleep is likely to be an important 
factor in NES, irrespective of the model used to explain its development.  
 
Sleep appears to be clinically meaningful and found to be related to functional 
impairment and mood and sleep interventions such as CBT-I have been found to be 
effective in improving sleep, mood and quality of life in neuropsychiatric and 
chronic conditions (Hingray et al., 2016). The extensive research in the relationship 
between epilepsy and sleep further implies that identifying and addressing sleep 
difficulties in epilepsy, could reduce seizure frequency (Malow, 2004; Accardo & 
Malow, 2015). This would indicate that it would be useful to investigate if sleep 
impacts on seizure frequency and if so, it stands to reason that a sleep intervention 
could possibly be tested to reduce seizure frequency in NES too. Furthermore, there 
are currently no agreed standard treatments for NES (Martlew et al., 2007; Smith, 
2014).  If sleep appears to be an important factor in NES then, as CBT-I has been 
found to effectively improve sleep (Manber et al., 2014), a next step would be to 






















2.1 Current understanding of Sleep in NES 
During the time in which this project was designed, research into sleep in NES had 
been limited to only two published studies. One, a cross-sectional study measuring 
subjective sleep (Graham & Kyle, 2017) and the other, a very small cross-sectional 
study (Bazil, Legros & Kenny, 2003) with no information on how sleep impacts on 
other clinically important factors in NES, such as dissociation, mood or seizures. 
Since then, four more papers have been published looking at sleep in NES. Two of 
these were cross-sectional, trait level questionnaire studies that found that people 
with NES subjectively report poorer sleep disturbances (Latreille et al., 2018; 






period limb movement than people with epilepsy (Popkirov, Stone & Derry, 2018). 
The final study used subjective and objective measures of sleep comparing NES and 
ES samples and suggest that both groups have similar sleep structure but that those 
with NES were more likely to subjective report poorer sleep (Latreille et al., 2019).  
 
Our study therefore aimed to address the gaps in these recent studies in sleep in 
NES. Firstly, it is important to measure both subjective and objective measures of 
sleep in NES as it is important to know whether sleep disturbances experienced are 
as a result of a sleep misperception. Moreover, subjective measures alone are unable 
to tell us anything about the characterisation of sleep in NES and studies that have 
included both subjective and objectives of sleep did not control for known sleep 
disorders ((Latreille et al., 2019).  Secondly, current studies of sleep in NES have 
compared this sample to those with epilepsy, failing to account for well documented 
understanding of disturbed sleep as a feature of epilepsy (Derry & Duncan, 2013). 
Our study has therefore used both subjective and objective measures of sleep, 
compared a NES sample to a control sample and sought to exclude participants with 
known sleep problems and epilepsy.  
 
Furthermore, research suggests that poor sleep is linked to increased dissociation 
and impaired mood (van Heugten-van der Kloet, Giesbrecht, & Merckelbach, 2015), 
which have both been found to be an important part of the process of seizures in 
NES (Hingray et al., 2016). It is therefore unsurprising that recent studies in sleep in 
NES have hypothesised that dissociation may be a key factor in impaired sleep in 






between sleep, dissociation and NES (Graham & Kyle, 2017; Popkirov et al., 2018).  
We therefore wanted to also explore whether sleep affected next day dissociation, 
mood and seizures as previous studies have not addressed these issues. 
 
2.2. Research Aim & Objectives  
To characterise sleep in NES, in terms of daily sleep behaviours, subjective and 
objectively measured sleep (see Figure 2).  
 
2.2.1. Objectives 
1. To assess whether people with NES appear to experience subjectively or 
objectively measured worse sleep than people without NES. 
 
We hypothesise people with NES will experience subjectively and 
objectively greater sleep impairment. We also hypothesise that those with 
NES will report a greater misperception between subjectively and 
objectively measured sleep.  
 
2. To prospectively investigate whether subjectively or objectively poorer sleep 
leads to higher levels of dissociation and lower mood on the next day. 
 
We hypothesise that impaired sleep the preceding night will lead to poorer 







3. If possible, to assess whether seizures occur more often on days following 
poor sleep, as opposed to days following better sleep in people with NES. 
 
We hypothesise that people with NES who experience impaired sleep the 
preceding night will have more seizures the following day.  
 
 



















Chapter 3. Methods 
3.1 Design  
This was a prospective, comparison study of subjectively and objectively measured 
daily sleep variables in a cohort of people with NES and a control group without 
seizure disorders. We have chosen this design in order to meet the current gap in 
research while attempting to account for the limitations acknowledged by other 
studies. 
 
3.2. Sample  
Clinical Sample 
For this study, we aimed to recruit individuals with a formal diagnosis of NES or 
NEAD from NHS services at the Leeds Teaching Trust, Sheffield Teaching Trust 
and Mid York Trust. To minimise the chances of recruiting individuals who may 
experience epileptic seizures but for whatever reason have not received a diagnosis 
of epilepsy, we only recruited individuals whose formal diagnosis had been made by 
a neurologist (see Table 1). Additionally, for more accurate sleep outcome measures, 
we excluded anyone with a known sleep disorder or chronic sleep problems.  
 
Individuals with dual diagnoses of NES and ES were excluded in this study as it is 
not always possible to distinguish between the different seizures. This would further 
not have allowed us to observe any possible links between sleep and the occurrence 
of non-epileptic seizures. We further excluded anyone reporting a risk of significant 







Table 1. NES Sample Inclusion and Exclusion Criteria 
 
Inclusion Criteria Exclusion Criteria 
 
Diagnosis of NES or NEAD made by a neurologist 
 
Dual Diagnosis of NES/NEAD and Epilepsy 
Under the treatment of a  recruitment centre Individuals with known sleep disorders. 
Able to wear an Actiwatch for a week Inability to speak and/or read English 
Between 18 and 70 years of age Reporting risk of self-harm or suicide   
Able to complete questionnaires either on paper or 
electronically  
Any physical or intellectual disability that would 





The participants for the control group were recruited from non-NHS settings, 
namely the University of Leeds participant database. This database consists mainly 
of University staff and students and other local volunteers who have chosen to be 
part of the pool of research volunteers. Similar to our clinical sample, we excluded 
participants with known sleep disorders or chronic sleep problems and anyone who 










Table 2. Control Sample Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
Able to wear an Actiwatch for a week 
Between 18 and 70 years of age 
Diagnosis of any seizure or sleep disorders 
Inability to speak and/or read English  
Able to complete questionnaires either on paper 
or electronically  
Reporting risk of self-harm or suicide   
Any physical or intellectual disability that would hinder 
their ability to give consent or to participate 
 
3.3 Sample Size 
We aimed to recruit N=25 individuals with NES and N=25 individuals without 
seizure disorders for our control group. Based on effect sizes from previously 
published research (Graham & Kyle, 2017), this sample size would allow us to 
investigate medium to large differences in sleep outcomes between those with NES 
and those without. The sample size further enabled us to investigate medium to large 
correlations between outcomes within our NES group.  
 
3.4.  Materials  
Data was collected in two stages and included several questionnaires recording 
sleep, mood, and dissociation, as well as recorded objective sleep parameters. In the 
first stage, participants completed a one-off battery of questionnaires, and in the 
second, they completed short daily measures and diaries. The measures and 







3.4.1. Baseline Measures 
Demographic information  
Participants were asked for their gender, age, ethnic background, the status of 
employment, whether they experienced seizures, and how many they experienced in 
an average month. This provided some basic background of our participants without 
compromising their anonymity. 
 
Pittsburgh Sleep Quality Index (PSQI)  
The PSQI (Buysse et al., 1999) is the most widely used psychometric measure of the 
quality of sleep (Lee, 2016). It has been used in studies for a variety of physical and 
mental health conditions and has been widely translated for cross-cultural use 
(Smith & Wegener, 2003). The PSQI measures sleep over a month and includes 
items assessing sleep efficiency, perceived sleep quality and daily disturbances 
(Cole et al., 2006). The PSQI consists of 19 items answered in both free text and 
four frequency options;  
 
- Not during the past month (scored as 0) 
- Less than once a week (scored as 1) 
- Once or twice a week (scored as 2) 








The PSQI measures sleep over seven domains; sleep latency (SL), total sleep time 
(TST), wakefulness after onset of sleep (WASO), sleep efficacy (SE), sleep 
disturbances (awakenings) and day-time functioning.  
 
Dissociative Experience Scale-II (DES-II) 
The DES-II (Carlson & Putnam, 1993) is an updated version of the DES (Bernstein 
& Putnam, 1986)	and is a trait measure of dissociation rather than a state measure. It 
contains 28 questions about dissociative experiences measured on a scale of 0 to 
100% and contains three sub-scales: amnesia, depersonalisation/derealisation and 
absorption. Essentially, the DES-II is the same as the DES but has a simplified 
scoring procedure and provides the average DES scores for a range of psychiatric 
conditions for comparison purposes. The DES-II further distinguishes between low 
and high scores by using a score of 30 or above to indicate high levels of 
dissociation.  
 
Generalised Anxiety Disorder 7 (GAD7) 
The GAD7 (Spitzer, Kroenke, Williams, & Löwe, 2006) is a questionnaire 
measuring the severity of anxiety. The GAD7 is widely used in outpatient and 
therapy services. The scale asks about symptoms that may have occurred in the last 
two weeks and consists of 7 questions that can be answered using four levels of 
frequencies: 
 
- Not at all (score of 0) 






- More than half the days (score of 2) 
- Nearly every day (score of 3) 
 
The GAD7 is scored by adding up all of the scores and using the total scores as an 
indication of the level of anxiety individuals report. A total score of 5 suggests low 
levels of anxiety, a total score of 10 suggests moderate anxiety and a score of 15 and 
above indicates severe anxiety.  When using the threshold of a total score of 10, the 
GAD7 has been found to have an 89% sensitivity of detecting anxiety (Kroenke et 
al., 2007). 
 
The Patient Health Questionnaire 9 (PHQ 9)  
The PHQ-9 (Kroenke, Spitzer & Williams, 2001) is used to monitor the severity of 
depressive symptoms. The PHQ-9 is widely used in outpatient and therapy services 
as well as in medical services to assess depression alongside physical conditions. 
The scale consists of 9 questions which are derived from the DSM-IV criteria of 
depression; however, the scale is not used as a diagnostic instrument. Like the 
GAD7, the PHQ-9 asks about symptoms in the past two weeks using four levels of 
frequencies; 
 
- Not at all (score of 0) 
- Several days (score of 1) 
- More than half the days (score of 2) 






The PHQ-9 is scored by adding up all of the scores and using the total scores as an 
indication of how much depressive symptoms individuals report. The cut-off scores 
for mild, moderate and severe are the same as they are for the GAD7. Furthermore, 
when using the threshold of a total score of 10 or above, the PHQ-9 has been found 




Participants with NES were also asked to report the number of seizures they 
experienced over the past month.  
 
The initial battery of questionnaires was collected and stored on Online Surveys 
(previously Bristol Online Surveys). This data is anonymous, and Online Surveys 
automatically assigned each participant a number, which was then be used to link 
data with the actigraphy and daily measures completed by each participant. This 
data was linked to demographic information, but these did not contain any 
identifiable or personal data.  
 
3.4.2. Daily Measures  
Actigraphy  
The gold standard objective measure of sleep is PSG, which measures several 
physiological processes in order to get detailed results about sleep experiences. PSG 






access. It has, therefore, been suggested that actigraphy measures such as the 
Actiwatch might be the next best objective measure of sleep for research purposes 
(Lee, 2016). The Actiwatch is a wrist-worn activity monitor that measures levels of 
activity, wakefulness and sleep by continuously capturing the level of movement 
and body position to indicate physical activity and waking and sleep cycles. While 
the Actiwatch does not provide details on sleep stages, it is considered a valid and 
useful tool in the measurement of objective total sleep time and the wakefulness 
after the onset of sleep in clinical populations (Marino et al., 2013).  For this study, 
we used the ActiGraph wGT3X-BT Actiwatch. The data collected from the 
Actiwatch was stored on the software provided by the makers of Actiwatch, 
Actigraph. This software is called ActiLife (version 6), which is used to both store 
and analyse the data collected from the Actiwatch. Actigraph will not have access to 
any of the data collected, stored and analysed on their software during this study. 
 
Consensus Sleep Diary (CSD) 
The CSD was developed by insomnia experts and service users (Carney et al., 2012) 
in an attempt to create a standardised sleep diary. It is a standardised dairy that 
collects data on time gone to bed, the onset of sleep, total sleep time, sleep 
disturbed, total time awake due to disturbances, wakefulness after sleep and 
perceived quality of sleep. It further notes activities such as naps during the day, the 
number of caffeinated drinks and medication. The CSD has previously been used 
alongside the PSQI and actigraphy (Landry, Best & Liu-Ambrose, 2015) and was 
found to correlate effectively with actigraphy (Grandner et al., 2006). Finally, the 







Daily measure of Dissociation  
To our knowledge, there are currently no short, daily scales that measure 
dissociation. We, therefore, developed a short measure using relevant items from 
existing measures. We used four items from the State Scale of Dissociation (SSD) 
developed by Krüger & Mace in 2002. This 56-item scale measures states of 
depersonalisation, derealisation, identity, confusion, identity alteration, amnesia and 
hypermnesia and was validated against the Dissociation Experience Scale (Bernstein 
& Putnam, 1986). The items are measured from “Not at all” to “Very much so”.  
Based on clinical experiences, we selected two depersonalisation and two 
derealisation items with good face validity and changed the wording to measure the 
state of dissociation daily as opposed to momentarily: 
 
- "Today, things around me seemed unreal or dreamlike."  
- "Things around me looked different today, from the way they usually do."  
- "Today, my body has felt vague, indefinite, strange."  
- “Today, my body seemed disconnected from my thoughts, my feelings, myself”  
 
Daily measure of Mood 
The international short-form measure for positive and negative affect (I-PANAS-SF, 
Thomson, 2007) measures daily mood. It consists of 10 items, measuring across five 
negative affects (upset, hostile, ashamed, nervous and afraid) and five positive 
affects (alert, inspired, determined, attentive and active). The measure asks, 






generally feel [item],” on a 5-point scale from “never” to “always”. The I-PANAS-
SF has been used as a daily measure of mood (Brogan & Hevey, 2013) and modified 
to ask, “indicate to what extent you felt this way during the day today”, on a 10-
point scale from “very little” to “very much” (Lacaille, Sadikaj, Nishioka, Flanders 
& Knäuper, 2015). For continuity between the daily measures in our study, the 
wording of the first point-scale to was changed to “not at all” and the last point-scale 
to “very much so”.  
 
Daily Seizure Record 
NES participants were asked to note the number of seizures they have experienced 
that day.  
 
The data collected from the daily scale for dissociation and mood, as well as the 
frequency of seizures experiences, were stored and managed using the SPSS 
programme. This database is anonymous, and participants are distinguished by the 
participants' number allocated to them by Online Surveys when they first partake.   
 
3.5. Study procedure 
3.5.1. NES Sample 
All potential participants were approached by their clinicians in routine 
appointments. Clinicians informed potential participants about the study by giving 
suitable patients a letter of invitation and a participant’s information sheet. The letter 






partake by informing their clinicians. After this, their names were passed on to me, 
and I contacted them within two weeks. I was in regular contact with the recruitment 
centres to be informed about potential participants. Once I was given the names and 
telephone numbers of individuals who expressed an interest in partaking, these were 
kept in the Study File at the recruitment centre.  
 
Potential participants were contacted at least 24 hours after receiving the 
participant’s information sheet. When interest in partaking was confirmed over the 
telephone, myself and potential participant agreed on a time and date to meet at the 
participant’s local hospital.  The I did not store this personal information, and all 
telephone calls were made from the admin offices of the site where the participant 
was approached. All participants were contacted within two weeks of receiving the 
participant's information sheet. 
 
3.5.2. Control Sample 
All our control participants were recruited from the University of Leeds’s pool of 
volunteers’ mailing list. A recruitment email was sent to the mailing list, outlining 
the study and how participants could contact the researcher to express an interest in 
participating. In an attempt to match the demographics of our prospective NES 
population, in the first instance, we sought out female participants over the age of 
25, in line with the findings that NES was more likely to be diagnosed from the 20s 
onwards (Ettinger et al., 1999). To ensure that our sample would include a wide 
range of ages, including older adults, we also recruited from the University of 






60. I was given access to this panel and contacted six individuals from this panel by 
email, one of whom agreed to take part.  
 
3.5.3. Stage 1 
The first stage of the study, the pre-participation meeting occurred in the 
participant's local health centre and lasted from 30 to 60 minutes per participant. I 
first sought to confirm the participant’s interest in partaking and ensured that all 
participants understood what was being asked of them. I then confirmed with all 
participants that they met the inclusion criteria and whether any of the exclusion 
criteria applied to them. Participants were then asked to read the consent form and 
sign this to indicate their understanding of participation and their rights as a 
volunteer in this study.  
 
Participants were then asked the completed the pre-participation battery of 
questionnaires (PSQI, GAD7, PHQ9, DES-II and demographic information). Most 
of the participants completed this electronically; however, some participants 
struggled to do so and requested to do this on paper instead. Upon completion of 
this, participants were talked through the second stage of this study, which they were 
to complete at home. I then set up the Actiwatch and demonstrated to participants 
how to use it. Participants were also shown the sleep diary and the dissociation and 
mood scale and given instructions on how to complete this over the next week. 
Participants were then offered a date and time to meet for a half an hour post-
participation meeting. Finally, all participants were given my contact details as the 






3.5.4. Stage 2  
During the second stage of this study, participants were asked to wear the Actiwatch 
continuously and only to remove this temporarily when they are taking a shower. 
Participants were also asked to complete a sleep diary upon waking and the 
dissociation and the mood scales before going to bed. Participants were further 
asked to note down the number of seizures they have experienced that day. 
Participants were encouraged to put reminders on their phone to complete their daily 
measures or to keep their folder next to their beds as a reminder to complete these. 
However, I did not keep a record of whether participants did either of these things.  
 
3.5.6. Stage 3 
In the final stage of the study, participants were asked to attend a half hour post-
participation meeting in which they returned the Actiwatch and the completed 
diaries and questionnaires. All participants were asked about their experiences of 
taking part in the research and whether there were any difficulties or issues they 
encountered. I informed the participants that an anonymised summary of the overall 
results will be shared with each recruitment centre and that they would be able to 
request access to this from their healthcare teams. All participants were then thanked 
for their participation and reimbursed for their travel costs with a £25 Love to Shop 
Voucher as standardly offered by the University of Leeds.  
 
3.6. Ethical Considerations 
3.6.1. Ethical Approval 






and the University of Leeds. We chose to seek ethical approval separately for our 
two groups as we anticipated that the ethical approval for our clinical sample might 
take some time and therefore intended to recruit our control sample while ethical 
approval was in process. Seeking approval separately enabled us to start the study 
before individual trust's approvals were in place, therefore avoiding a delay in the 
start of recruitment. 
 
Ethical approval for this study was granted from the NHS Research Ethics 
Committee (IRAS project number: 239312) on 12th of September 2018 and from 
the Ethics committee at The School of Psychology at the University of Leeds (PSC-
431) on the 18th of September 2018.  
 
3.6.2. Risk Management 
There was the possibility that some participants might have found it distressing to 
complete questionnaires about their mood, in particular, one of the questions on the 
PHQ-9 that asks about thoughts concerning self-harm and suicide. Participants were 
told at the start that while the content of their contact with me was confidential, that 
if they share anything that indicates a risk to themselves or others, that their 
healthcare team would be informed. Furthermore, these initial questionnaires were 
completed on a tablet in the presence of myself and care was taken to not include 
sensitive questions in the daily measures completed by participants in their homes.  
 
For this study, we also produced a risk management plan if a significant risk to self 






courses of action. For participants who were not currently under the care of a 
psychology or psychotherapy team, they would be signposted to their GP. For 
participants who indicate that they are at immediate risk of harm, local safeguarding 
leads would be contacted by myself for further guidance and advice. A copy of the 
risk protocol was kept in the Study File at all times.  
 
3.6.3. Data protection & Confidentiality  
Personal data, in particular, names and phone numbers were used to contact 
participants to set a date and time for the pre-participation meetings. This data was 
then recorded on a paper sheet which was kept in the Study File, in a locked drawer 
at the recruitment centre. This data was not collected for any other purposes than 
contact and was only accessed at the study site to make telephone contact with the 
participants. All signed consent forms were also kept in the Study File, and upon 
completion, these were scanned into a password protected secure drive on 
University computers and not linked to the data collected in any way. The paper 
copies of the consent forms were shredded. The University Information Protection 
Policy and the DClinPsychol Policy on Safeguarding Sensitive Data was followed.  
 
3.7. Recruitment Barriers 
Several barriers made the process of recruitment more challenging than initially 
expected. Firstly, due to loss off access to intended funding, our recruitment samples 
had to be reduced to N=20 in each group. Secondly, while ethical approval had been 






approvals took a further four months. Recruitment of the clinical sample, therefore, 
began in January 2019.   
 
Thirdly, we did not account for a large number of individuals with NES, who also 
experienced a brain injury (Westbrook, Devinsky & Geocadin, 1998). As brain 
injuries are linked to sleep difficulties (Castriotta & Murthy, 2011) and memory 
difficulties (Smith, Okiyama, Thomas, Claussen & McIntosh, 1991), we decided 
that this would not give us an accurate reflection of sleep and have therefore decided 
not to include anyone with a history of brain injury in this study. However, in doing 
so, we limited the pool of potential participants. Similarly, I had failed to account for 
other physical and emotional difficulties that would not allow participants to 
complete the pre-participation meeting in half an hour. There were also times during 
recruitment in which participants experiences seizures, further increasing the time it 
took to complete the initial meetings.  
 
Fourthly, many participants required hospital transport to attend hospital 
appointments and were unable to attend the research meetings without transport 
arrangements. As we were unable to meet these needs financially and to avoid any 
costs to the recruitment trusts, participants unable to attend these meetings were 
unfortunately not able to participate. Finally, many of the participants contacted 
expressed an interest to be seen either before or after their routine appointments such 
as therapy sessions. However, this was difficult to facilitate due to time and room 







3.8. Data Analysis  
The data collected from the Actiwatch was processed using the ActiLife software, 
which establishes the levels of activity and sleep of the duration participants wear 
the Actiwatch. The ActiLife software requires information about time gone to bed 
and time out of bed from the sleep diary to produce Actigraphy output (see 
Appendix 8.4.1), which was then added to the data comprising sleep, dissociation, 
mood and seizure frequency outcomes and analysed using SPSS.  We used 
independent sample T-Tests with Bonferroni Corrections to explore whether there is 
a difference in these measures between those with NES and the control group. We 
further planned to explore whether there is a relationship between the measures of 
sleep, dissociation, mood and seizure frequency by multi-level modelling. As SPSS 
is not considered the most effective software for multi-level modelling (Sommet & 
Morselli, 2017), we used R to explore whether seizure occurrence was linked to the 
impaired sleep the night before using a mixed effects logistic model. We also used a 
mixed linear effect model to assess whether next day dissociation and negative 
mood was affected by sleep the night before.  
 
3.9 Max Hamilton Fund 
I received £200 from the Max Hamilton Fund at the University of Leeds to 
supplement my research budget as I no longer had access to intended additional 
funding agreed to reimburse my participants. As we did not meet our planned 






Chapter 4. Results 
 
4.1 Sample Demographics  
In total, 20 control participants and 17 NES participants completed the study. I 
initially recruited 27 NES participants, however, nine were unable to partake as 
either their physical or emotional wellbeing had deteriorated, and one participant did 
not attend. All 17 NES participants were recruited from the Sheffield Teaching 
Hospitals site. Both groups had similar age ranges and gender distributions. The 
ethnicity of the participants differed somewhat across the group as the control group 
included four participants that identified as black, Asian or of mixed heritage. In 
relation to the employment, only 33% of NES participants were employed full-time, 
compared to 70% of the control group. However, there were more people in the NES 
group that worked part-time (11.8%) when compared to those in the control group 
(5%; Table 1). Finally, 76.5% of our NES sample was either currently undergoing 
psychotherapy or had completed psychotherapy within a month of participation.  
 
Table 3. Sample Demographics 





























(PART-TIME %) 5 11.8 






4.2 Baseline outcomes  
Outcomes measured at baseline were compared using an independent sample t-test 
with a Bonferroni Correction of p £ 0.01. This showed that there are significant 
differences between the groups on all measured trait properties; sleep, dissociation, 
anxiety and depression (see Table 3).  
 
The PSQI is scored using a global score between 0 (no sleep difficulties) and 21 
(severe sleep difficulties) without suggested cut-off points. On average, those in the 
NES group reported significantly poorer overall sleep; t (26.7) =6.8, p £ 0.001 and 
with a large effect size, r = .80, when compared to the control group. 
 
The DES-II scale used a cut-off point of 30 to distinguish between low and high 
levels of dissociation, with a suggestion that the average score for the general 
population is 5.4. Those in the NES group reported significantly higher levels of 
dissociation than those in the control group; t (20.2) = 4.7, p £ 0.001 and represented 
a large effect size, r = .72. The results further show that both groups experience 
much higher dissociation than authors of the scale indicate as cut-off points for 
different psychiatric diagnoses.  
 
The GAD7 cut-off points are 5 for mild, 10 for moderate and 15 for severe anxiety 
experienced. Our results show that the NES group scored an average between the 






the cut-off point for mild anxiety. The difference between the groups was statically 
significant; t (21.5) = 5.4, p £ 0.001 and represented a large effect size, r = .76.  
 
The PHQ-9 cut-off points are 5 for mild, 10 for moderate, 15 for moderately severe 
and 20 for severe depression. As shown in Table 2 the NES participants scored close 
to moderately severe depression whereas the control group scored below the cut-off 
point for mild depression. The difference between the groups was large and 
statistically significant; t (22.5) = 7.2, p £ 0.001. Furthermore, the number of 
seizures experiences by the NES group ranged from 0 (less than 1 a month) to 150 
seizures a month, with an average of 2.4 seizures a month.  
 
Table 4. Mean & Standard Deviations of Baseline Outcomes 
 
 








p = 0.000 (r = 0.80) ** 
DES-II 23.9 (20.3) 86.6 (51.5) p = 0.000 (r = 0.72) ** 
GAD7 3.7 (2.9) 12.7 (6.4) p = 0.000 (r = 0.76) ** 
PHQ-9 3.2 (3) 14.9 (6.1) p = 0.000 (r = 0.84) ** 
SEIZURE FREQUENCY  - 21.4 (38.2)  
 








On the PSQI, the NES group reported getting significantly more sleep disturbances, 
less sleep, poorer quality sleep and worse daytime functioning than the control 
group., However, there did not appear to be a significant difference between the 
groups in the use of sleep medication (see Table 5).  
Table 5. Baseline PSQI Sleep Components 
 








p =0.000 (r = .73) ** 
LATENCY .70 (1) 2.53 (80) p  =0.000 (r = .72) ** 
DURATION .30 (.57) 2.13 (1.26) p =0.000 (r = .77) ** 
EFFENCIENCY 55 (.76) 2.19 (1.11) p =0.000 (r = .71) ** 
DISTURBANCE 1.21 (.54) 1.88 (.78) p =0.006 (r = .49) * 
MEDICATION .10 (.45) .47 (1) p =.175 (r = .29) 
DAY-TIME FUNCTION 
 
1 (.65) 1.82 (.88) p =0.003 (r = .51) * 
 
* p £ 0.01, ** p £ 0.001 
 
4.3 Objectives 
4.3.1 To assess whether people with NES appear to experience subjectively or 
objectively measured worse sleep than people without NES. 
Hypothesis 1: People with NES will report greater subjective sleep impairment 
The averages of each group’s subjective measures of sleep collected from the sleep 






correction of p = 0.01. There were no significant differences in: 
 
- Sleep Latency (SL) Time between trying to sleep and falling asleep.  
- Sleep Efficiency (SE) The percentage of actual sleep out of the total time in bed. 
- Total Time in Bed (TIB) Time between getting into bed and getting out of bed. 
- Total Sleep Time (TST) Total time of actual sleep.  
- Wakefulness After Onset of Sleep (WASO) Time spend awake after sleep onset  
- The number of awakenings during sleep.  
 
There was, however, a significant difference in Sleep Quality (SQ), which refers to 
the subjective perceptions of the overall quality of sleep and is measured on scaled 
scores of 0 (very good), 1 (good), 2 (fair), 3 (poor) and 4 (very poor). The NES 
group reported significantly poorer SQ than the control group; t (33.2) = - 4.2, p £ 
0.001, with a large effect size of r = .57. The SQ was the only statically significant 
difference across all sleep domains between the two groups.  
 
Hypothesis 2: People with NES will experience greater objective sleep 
impairment 
Objective measures of sleep were collected by the Actiwatch and analysed using the 
ActiLife software. The Actiwatch must be used with a sleep diary as the software 
requires a time gone to bed and a time out of bed in order to compute the sleep 
properties. The software then produces an actigraphy output for each day and 






This data was then further analysed using an independent samples t-tests, with a 
Bonferroni Correction of p = 0.01.  
 
There were no significant differences between the two groups in objectively 
measures SL, TIB and TST. The NES group experienced significantly more WASO 
than the control group; t (23.5) = 3.7, p £ 0.001 and represented a large effect size, r 
= .60. The NES participants experienced almost twice as much objectively measured 
WASO than the control group (see Table 6).  
 
The NES group also experienced significantly less SE than the control group; t 
(24.9) = -3.7, p £ 0.001 and represented a large effect size, r = 60. The PSQI 
suggests that SE below 85% indicates difficulties with sleep and our results show 
that both groups scored below this threshold with subjectively measured SE, 
however the control group this meet this threshold with objectively measured SE.  
Furthermore, the NES group experienced significantly more awakenings during 
sleep when compared to the control group; t (34.6) = 3.8, p £ 0.001, with a large 












Table 6. Subjective & Objective Outcomes of Daily Sleep 
 
 
* p£ 0.01, ** p £ 0.001 
 
Hypothesis 3: People with NES will show greater misperception of sleep 
An independent samples t-test with a Bonferroni correction of p = 0.01 was 
conducted to assess a difference between the groups in the misperception, or the gap 
between their subjective and objective measures of sleep. The outcomes show that 
there were no significant differences between the two groups’ misperception across 





























































































































Table 7. The Misperception between Subjective & Objective Outcomes of Sleep 
 
 
The results also show that both groups underestimated or under-reported the number 
of awakenings they experienced. In fact, both groups under-estimated their number 
of awakenings by 87.2% (see Figure 3). 
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4.3.2. To prospectively investigate whether subjectively or objectively poorer sleep 
leads to higher levels of dissociation and lower mood on the next day. 
 
Hypothesis: Impaired sleep on preceding night, will lead to poorer next day 
mood and dissociation 
Before I looked at the relationship between impaired sleep and functioning, I 
analysed the measures of mood and dissociation using an independent samples t-test 
with a Bonferroni correction of p = 0.01 (see Table 8). The results showed that the 
control group, on average experienced significantly more Positive Affect (PA) than 
the NES group; t (31.) = -2.9, p £ 0.01 and represented a medium effect size of r = 
.46. Additionally, the NES group reported significantly more dissociation than the 
control group; t (18.8) = 6.9, p £ 0.001 and represented a large effect size of r = .85. 
On average, the NES group experienced seizures daily (M = 1.1, SD = 1.7).  
 
Table 8. Mood, Dissociation and Seizure Frequency outcomes. 
 
 CONTROL (N=20) NES (N=17) DIFFERENCE 
PA 28 (9.3) 18 (11.)  p = 0.007 (r = .46) * 
NA 9.4 (4.3) 14.8 (9.4) p = 0.040 (r = .43)  
DISSOCIATION 1.2 (.48) 3.8 (1.5) p = 0.000 (r = .85) ** 
SEIZURE FREQUENCY  1.1 (1.7)  
 
 








As the results show that the NES sample presented with objectively poorer sleep 
across the sleep domains of SE, WASO and awakenings and reported higher levels 
of state dissociation, we aimed to further explore the relationships between sleep and 
next day dissociation. We fitted a mixed linear effect regression model to analyse 
the relationship between dissociation and preceding night’s sleep, using the 
objective measures of SE, TST, WASO and awakenings. To select the most 
appropriate covariates, a LASSO regression model was fit to identify key variables, 
before refitting the model with no regularization (see Appendix 8.4.3.2). The 
resulting model found no strong association between SE and dissociation (C= 0.01; 
CI [-0.03, 0.05]; p = 0.573), between WASO and dissociation; (C = 0.0000684; CI [- 
0.005, 0.005]; p = 0.980) and between number of awakenings and dissociation (C = 
-0.03; CI [-0.068, 0.006]; p = 0.101).   
 
The model did however show an association between having NES and experiencing 
dissociation; (C = 1.33; CI [0.52, 2.13]; p = 0.002) and that having dissociation on 
the preceding day was strongly associated with experiencing dissociation the 
following day;  (C= 0.484; CI [0.283, 0.684]; p = 0.000). This model suggests that 
preceding night’s sleep was not associated with next day dissociation. However, it 
does show that there is an association between having NES and next day 
dissociation and preceding day dissociation and next day dissociation.  This suggests 
that those with NES were more likely to report high levels of dissociation. It also 
indicates that high levels of dissociation on the preceding day, was strongly 







Next, we fitted another mixed linear effect regression model to analyse the 
relationship between NA and preceding night’s sleep, using the objective measures 
of SE, TST, WASO and awakenings (see Appendix 8.4.3.3). Like above, a LASSO 
regression model was fit to identify key variables before refitting the model with no 
regularization on the reduced set of variables. The regularisation strength was 
determined using a grid search aiming to minimize the Akaike Information Criterion 
(AIC). The resulting model found no strong association between we found no strong 
associations between TST and NA; (C = -0.0012543; CI [-0.0030, 0.0005]; p = 
0.170). Following a LASSO analysis, the sleep variables of SE, WASO and 
awakenings were removed, suggesting no associations between these variables and 
NA. A Pearson Correlation was conducted afterwards to confirm that there were no 
detectable associations between the removed sleep variables and NA.  
 
4.3.2. If possible, to assess whether seizures occur more often on days following 
poor sleep, as opposed to days following better sleep in people with NES 
Hypothesis: Impaired sleep on preceding night, will lead to more seizures the 
next day  
We fitted a multivariate mixed effects logistic regression model to analyse the 
relationship between seizures and preceding night’s sleep, while controlling for 
dissociation and mood. The random effect is used to give individual patients unique 
intercepts which helps to control for the effect of any other patient characteristics 
effecting the outcome which were not collected within our data. Additionally, all 
continuous variables were normalised by the changing the means to 0 and the 






covariates, a LASSO regression model was fit to identify key variables, before 
refitting the model with no regularization on the reduced set of variables. The 
regularization strength was determined using a grid search aiming to minimize the 
AIC. The resulting model did not show any strong association between seizure 
frequency and WASO (OR = 1.65; CI [0.44, 6.23]; p = 0.460) and between seizure 


















Chapter 5. Discussion 
I set out to assess whether people with NES appear to experience subjectively or 
objectively measured worse sleep than people without NES. I hypothesised that 
people with NES would experience subjectively and objectively greater sleep 
impairment and that they would report a greater misperception between subjectively 
and objectively measured sleep. I then explored whether preceding night’s sleep 
would affect next day mood, dissociation and seizure frequency.  
 
5.1. Do people with NES experience subjectively and objectively worse sleep? 
5.1.1. Hypothesis: People with NES will report greater daily subjective sleep 
impairment 
On average, the NES sample reported poorer outcomes on all sleep domains; 
however, this difference was only significant for SQ. This is in line with current 
findings from cross-sectional studies that those with functional symptoms such as 
NES are likely to report subjectively poor sleep (Graham & Kyle, 2017; Erickson et 
al., 2019). Moreover, it has been suggested that SQ is a better indicator of overall 
wellbeing than the actual amount of total sleep (Pilcher et al., 1997), which in turn is 
likely to be a reflection of the well-documented link between mood and sleep.  
 
Furthermore, it has been found that mood, in particular depression is a better 
predictor of subjective SQ than PSG measured impaired sleep, even in the presence 
of sleep disorders such as Obstructive Sleep Apnoea (Wells, Day, Carney, Freedland 






perceive their difficulties as more disabling (Frances et al., 1999), that self-reported 
perception of sleep are equally important when exploring the impact of sleep on 
overall wellbeing. In fact, those who report a better SQ are also more likely to report 
their overall wellbeing and quality of life as better (Jean-Louis et al., 2000). 
Therefore, if we assume that subjective measures of sleep do not impact on 
functioning, we risk minimising sleep problems and in turn, might be less likely to 
offer interventions to improve sleep if sleep problems are not considered “real”.  
 
5.1.2. Hypothesis 2: People with NES will experience greater objective sleep 
impairment 
The objective daily sleep outcomes showed that on average, those with NES 
experienced poorer sleep across all the sleep domains. These differences were 
significant, for three of the sleep domains in which the NES sample experienced 
more WASO and awakenings, and significantly less SE. This differs slightly from a 
similar study in which they found that those with NES did not experience 
objectively worse sleep on any other domain than SL (Latreille et al., 2019). That 
being said, this study compared the sleep in NES and epilepsy samples, and 
impaired sleep is a known feature in epilepsy (Derry & Duncan, 2013). Furthermore, 
high frequency of awakenings (Taylor, Lichstein, Durrence, Reidel & Bush, 2005) 
and poorer sleep efficiency as a result of excessive nocturnal wakefulness (Hein, 
Lanquart, Loas, Hubain & Linkowski, 2017) have previously been considered to 
characterise sleep problems in depression. This suggests that those with NES present 
with a similar sleep architecture those living with depression, as previously 






Furthermore, it is important to note that SE encompasses both WASO and 
awakenings as the overall variable indicating time not spend sleeping following the 
onset of sleep; therefore, WASO and awakenings are not independent of SE. 
 
Theories into how people with NES perceive and process experiences generally 
imply that they were likely to over-estimate whether their sleep was impaired. 
However, our objectively measured sleep outcomes show that people with NES do 
spend more time awake after the onset of sleep and do experience a higher 
frequency of awakenings, therefore suggesting that those with NES do have actual 
poorer sleep. The number of objectively measured awakenings in the NES sample 
(21.2 ± 7.2) was comparable to a sample with co-occurring Obstructive Sleep 
Apnoea and Periodic Limb Movement Disorder (20 ± 20.26) (Kushina et al., 2001). 
This supports findings that people with NES experience more movement in their 
sleep (Popkirov, Stone & Derry, 2018) and may be experiencing disturbances 
comparable to those with diagnoses of sleep conditions.  
 
Additionally, it is not uncommon for people with NES to report that they experience 
seizures during their sleep (Thacker et al., 1993; Duncan et al., 2004) and the higher 
frequency of awakenings or movements observed in our study may elude to 
nocturnal experiences of seizures. That being said, a study exploring nocturnal 
seizures in NES suggests that rather than seizures occurring in sleep, they appeared 
to occur in what is considered pseudo-sleep, i.e. may appear to be asleep but EEG 
measurement indicate evidence of wakefulness (Benbadis, Lancman, Wolf & 






5.1.3. Hypothesis 3: People with NES will show greater misperception of sleep 
I were particularly interested in whether there would be a difference between the 
two groups in the misperception of sleep, i.e. the gap between subjectively and 
objectively measured sleep. The results showed that on average, the NES group had 
a larger misperception across all measured sleep domains than the control group. 
However, none of these differences was significant. Interestingly, both groups 
under-estimated their number of awakenings by 87%, suggesting that both groups 
experienced more awakenings than they subjectively perceived.  
 
It is important to note that while actigraphy has been considered the best objective 
measure of sleep in the absence of PSG (Lee, 2016) and suggested to be useful in 
the measurement of WASO and TST (Marino et al., 2013), it does in fact only 
measure movement and that it computes lack of movement as sleep. Additionally, 
actigraphy has been suggested to be less accurate when measuring sleep in samples 
with high levels of WASO (Paquet, Kawinska & Carrier, 2007), such as our NES 
sample. Furthermore, it has been previously found that actigraphy recorded 
awakenings were significantly more than self-reported awakenings (Lockley, Skene 
& Arendt 1999) and this is likely to be influenced by the differences between how 
awakenings are measured. For example, actigraphy awakenings are measured by 
movement as opposed to "being awake", whereas the participants are only able to 
report on awakenings while they were aware of being woken up. That being said, 
actigraphy awakenings are comparable to those measured by PSG (Lichstein et al., 
2006) and therefore, perhaps a better indication of awakenings than the sleep diary. 






sleeping and awakenings that include "being awake", to account for the large 
discrepancies between subjective and objectively measured awakenings.  
 
Moreover, while I collected data on whether participants took medication 
specifically for sleep, I did not collect data on the use of anti-depressants, which are 
known to impact on sleep (Wilson & Argyropoulos, 2005). It is also important to 
acknowledge that the differences in sleep across seasons have been well-
documented and findings suggest that we sleep more in the winter when compared 
to spring and summer (O’Connell, Griffiths, & Clemes, 2014). The control group 
was recruited between November and January and while the NES group was 
recruited between January and June and although the NES sample did not report less 
objective total sleep time, they did experience more sleep disturbances, which may 
have been influenced by seasonal impact on sleep.  
 
5.2. Does subjectively or objectively measured impaired sleep lead to poorer 
functioning the following day?  
5.2.1. Hypothesis: Impaired sleep on a preceding night, will lead to poorer next 
day mood and dissociation   
Before exploring whether sleep had an impact on next day functioning, I first looked 
at the level of functioning, in this case, mood and dissociation, that was reported by 
the groups across the week. The results for the daily measures of mood and 
dissociation indicate that the control participants, on average, reported significantly 






the baseline outcomes for mood and dissociation and therefore, as expected, 
suggests that trait properties of mood and dissociation can predict state mood and 
dissociation. These results support existing knowledge, as outlined above, that 
impaired mood (Mökleby et al., 2002; Prueter et al., 2002; Seneviratne et al., 2011) 
and higher levels of dissociation (Williams et al., 1993; Mazza et al., 2009; Van der 
Kruijs et al., 2011) are documented extensively in NES research.  
 
To explore whether impaired sleep on a preceding night affects mood and 
dissociation on the following day, we fitted mixed-effects logistic regression using 
objective measures of SE, WASO and awakenings as the outcomes of these sleep 
domains suggested impaired sleep. We also added TST to account for whether this 
might also have an impact. We found no strong associations between these variables 
of sleep and dissociation and NA. This is likely to have been affected due to our 
sample being underpowered. Furthermore, following the LASSO analysis, all sleep 
variables apart from TST were removed for our NA model, we can, therefore, 
assume that there was no strong association between these measures of impaired 
sleep. This was further confirmed with a Pearson Correlation, which demonstrated 
no strong relationships between our variables of impaired sleep and NA.  
 
Furthermore, as the LASSO analysis appeared to have successfully “pruned” out the 
variables with the least strength in association, we may have been underpowered in 
the length of the study rather than sample size. Nonetheless, causality between sleep 
and mood is known to be challenging to explore as mood has been found to predict 






Fröjmark & Lindblom, K. (2008). It has, therefore, been suggested that the 
relationship between sleep and mood should always be considered bi-directional 
(Alvaro, Roberts & Harris, 2013).  
 
Furthermore, in line with current findings, we found that our NES sample 
experienced significantly more impaired sleep and significantly higher levels of 
dissociation across the study period (Giesbrecht & Merckelbach, 2004). However, 
we were unable to find a strong relationship between these variables. Instead, we 
found that NA on a preceding day was associated with less NA the day after, 
perhaps indicating a regression to the mean. We further found that levels of 
dissociation the preceding day were associated with dissociation the following day, 
suggesting that perhaps experiences of dissociation lasted longer than a day and 
instead were experienced for more extended periods. This was unexpected 
considering the research base showing an association between sleep and dissociation 
and findings that suggest that dissociation is worsened after impaired sleep (Van der 
Kloet et al., 2012).   
 
That being said, our daily dissociation measure was not a standardised questionnaire 
as we were unable to find a state dissociation questionnaire that could be completed 
daily. Instead, based on clinical experience, we selected two depersonalisation and 
two derealisation items from the SSD (Krüger & Mace, 2002), which was validated 
against the DES. We chose not to include items that could be interpreted in several 
ways such as “I am in a world of my own at the moment” and those that could be 






information”. We also avoided items that indicated experiences linked to DID such 
as “Someone else is in control now” and “My inner voices are talking”.  However, 
it is possible that the daily dissociation outcomes might have been different had we 
chosen different items from the SSD. Furthermore, the daily dissociation outcomes 
from our control group show minimal experiences of dissociation, which is in 
contrast with the baseline outcomes of dissociation for the control participants. 
 
5.3. Does impaired sleep on a preceding night, lead the more seizures the following 
day?  
5.3.1. Hypothesis: Impaired sleep on a preceding night, will lead to more 
seizures the next day 
In the NES sample, 15/17 participants regularly experienced at least one seizure a 
month and reported seizure frequency ranged from 1 to 34 seizures over six days. 
Our outcomes from the multivariate mixed-effects logistic regression model showed 
no strong associations between our objective measures of SE, WASO, TST and 
awakenings and seizure frequency. Nonetheless, there did appear to be a promising 
association between the number of awakenings in the preceding night and next day 
seizure frequency (OR = 0.20; CI [0.98, 26.55]; p = 0.053), suggesting that this 
association may have been stronger if our sample was not underpowered.  
 
Nonetheless, mood and dissociation were controlled for mood in this model, which 
may have reduced the power of our sample and impacted whether any direct 






Furthermore, as there is currently no research that addresses the direct link between 
sleep and seizure frequency, we are unable to draw any assumptions about this 
relationship. However, extensive research in the relationship between epilepsy and 
sleep does suggest that identifying and addressing sleep difficulties in epilepsy could 
reduce seizure frequency (Malow, 2004; Accardo & Malow, 2015). This indicates 
that the impact of sleep in seizures may be worth further exploration.  
 
5.4 Sample demographics  
The gender distribution in the NES participants (76.2 % females) are comparable the 
suggestive figures that 60-75% of NES sufferers are female (O’Sullivan, 2007; 
McKenzie, Russell, Pelosi & Duncan, 2010). This could be explained by the over-
representation of women in traumatised populations, characterised by the high 
prevalence of gender-based violence and abuse, in the context of systemic 
oppression (Segalo, 2015). That being said, other research claims that women do not 
experience a higher prevalence of interpersonal traumatic experiences but rather that 
they appear to be twice as likely to be vulnerable in developing psychological 
difficulties following these experiences (Breslau, Chilcoat, Kessler, Peterson & 
Lucia, 1999).  
 
Similarly, the mean age of the NES sample (38.6 ± 16.2) was comparable to that in a 
recent similar study looking into sleep in NES by Latreille and colleagues (2018) 
with a large (N=149) NES sample (38 ± 13.3). Moreover, in line with the majority 
of research in NES, many of the participants were of white ethnicity. However it is 






psychotherapy service and people of ethnic minority groups are less likely to be 
referred to talking therapies (Rabiee & Smith, 2014), despite findings of high 
prevalence of NES in immigrants and refugees (Brickmann et al., 2018). Finally, 
many NES studies have found consistently that those in their samples reported low 
levels of employment and figures to suggest that less than half of those with NES 
are employed (Carton et al., 2003; Al Marzooqi et al., 2004; Karakis et al., 2014). In 
line with this, only 35.3% of the NES sample reported they were in full-time 
employment compared to 70% of the control sample. It is thoughts that 
unemployment in NES is linked to psychiatric comorbidity (McKenzie, Graham & 
Duncan, 2016) and may, therefore, continue to be a feature even when medically 
unexplained symptoms are accounted for.   
 
5.5. Baseline Outcomes 
5.5.1. Baseline Mood 
The baseline mood outcomes suggest that the NES group report significantly more 
anxiety and depression and is in line with the current understanding that people with 
NES also experience anxiety and depression (Mökleby et al., 2002; Prueter et al., 
2002; Seneviratne et al., 2011) and suggests our sample was comparable to other 
NES research samples. Nevertheless, like much of the research into mood in NES, 
our results are unable to show whether impaired mood precedes the development of 
NES or whether it develops as a result of living with NES.  
 
However, 76.5% of our NES sample had either recently completed or was currently 






which is likely to have influenced their mood outcomes. On the one hand, getting 
worse before “getting better” is a well-documented phenomenon in psychotherapy 
(Min & Yong, 2009; Joseph, Murphy & Regel, 2012; Owen et al., 2015) and this 
could have contributed to the high levels of anxiety and depression reported by our 
sample. On the other, there may also be the possibility that the mood outcomes in 
our study are "improved" and mood may even be more impaired in an NES 
population not accessing psychotherapy. Furthermore, I did not have access to the 
baseline mood outcomes for these participants collected routinely by the service and 
am, therefore, unable to draw any conclusions about the baseline mood outcomes in 
the NES sample. Additionally, our sample was too small to distinguish between the 
results of those in therapy and those who were not, without comprising participants’ 
anonymity.  
 
In hindsight, I might have had a better understanding of mood in NES if I included 
measures to assess the transdiagnostic processes across impaired mood such as 
threat perception, unhelpful coping and likelihood to experience distress and 
emotions as more overwhelming. This might have told us more about the underlying 
processes that contributed to the development or maintenance of NES and might 
have better enabled us to theorise the psychological functioning of NES. However, 
our study was not conducted to understand the role of mood in NES; instead, it was 
specifically aimed at understanding sleep in NES and mood was measured to be able 







5.5.2. Baseline Dissociation 
The baseline dissociation outcomes show that the NES group experienced 
significantly more trait dissociation than our control group as measured by the DES-
II. This is in support of the extensive findings that dissociation is a crucial process in 
NES (Williams et al., 1993; Wood, McDaniel & Burchfiel, 1998; Meller, 2005). 
Surprisingly, while the control group’s outcomes suggest that they experienced 
significantly less dissociation, their average scores (23.9 ± 20.3) are much higher 
than what the authors of the DES-II suggest is the average for the general 
population. The control sample scored higher than the suggested cut-off for eating 
disorders (15.8), schizophrenia (15.4) and BPD (19.2), (Coons et al., 1989), despite 
their mood outcomes suggesting that this group experienced relatively little mood 
difficulties.  
 
One possible explanation might be that some of the items on the scale could be 
interpreted in more ways than one. For example, item 11 states "Some people have 
the experience of looking in a mirror and not recognising themselves", and some 
people may interpret this in relation to their physical appearances having changed in 
some way rather than a depersonalisation experience in which they do not recognise 
themselves. Furthermore, I did not collect any information on the overall physical 
wellbeing of our samples, and as dissociation may also occur alongside organic and 
medical conditions (Good, 1993), it is possible that the control group's high levels of 
dissociation could be accounted for by unmeasured variables of physical health. 
That being said, these are assumptions, and I am not sure of the exact reasons behind 






On the one hand, the high dissociation outcomes in the control group, could suggest 
that dissociation alone may not be a factor in developing NES, on the other, as the 
NES participants' outcome was nearly four times as high as the control group, it 
could be hypothesised that unusually high experiences of dissociation are unique to 
NES. Furthermore, the NES mood outcomes was suggestive of moderate to 
moderately severe depression alongside high levels of dissociation, possibly 
indicating that there might be a relationship between dissociation and depression in 
NES, as previous suggested (Mazza et al., 2009). However, previous NES studies 
using the DES found that only 15.3% of their NES sample scored ³30 (Reuber et al., 
2003), compared to our sample in which 88% of NES participants scored ³30.  
 
Furthermore, our NES sample’s average DES-II scores (86.6 ± 51.5) are 
considerably higher than Carlson & Putnam's (1993) cut-off points for Dissociative 
Disorder Not Otherwise Specified (36) and Dissociation Identity Disorder (48). This 
may indicate that our dissociation outcomes are not comparable to other similar 
studies and are perhaps influenced by the small sample size or unknown or 
unmeasured variables that have contributed to our results.  Additionally, the DES 
was last updated in 1993, and while it is a widely used and well-recognised tool to 
indicate dissociation as a trait, it is possible that it does not capture our current 
understanding of dissociation which has continued to develop since. 
 
5.5.3. Baseline Sleep 
The baseline sleep outcomes indicate that NES participants in our study reported 






looking at the individual sleep domains separately; the NES group reported that it 
took them significantly longer to fall asleep, that their sleep was shorter and less 
efficient, that they experienced more sleep disturbances and that their daytime 
functioning was more impaired. The only sleep domain in which the two groups did 
not differ was whether participants had taken medication specifically to help them 
sleep in the past month. The results support the findings of recent NES research 
suggesting that this group of people are more likely to report impaired sleep 
(Latreille et al., 2018; Erickson et al., 2019).  
 
A possible explanation for our sleep outcomes might be that people with NES are 
thought to have a reduced ability to cope with stress (Testa et al., 2012), which in 
turn has been linked with impaired sleep (Sadeh et al., 2004). Alternatively, as those 
with NES are thought to consider their overall health as poor (Al Marzooqi et al., 
2004), it is likely that they also perceive their sleep to be more impaired than it is. 
However, these conceptualisations are based on assumptions that people with NES 
perceive their functioning to be more impaired as opposed to objectively 
experiencing poorer health. Furthermore, it is worth mentioning that anecdotally, the 
majority of NES participants verbalised that they found this questionnaire 
challenging to complete. In particular, they reported that they found it difficult to 
remember what their sleep was like and the nature of this questionnaire requires 
those completing it to estimate what their sleep has been like over the past month. It 
has been suggested before that those with NES might have difficulties with their 
working memory (Strutt et al., 2011) and may have contributed to the difficulties 






5.6. Methodological considerations 
5.6.1. Strengths  
To our knowledge, this study was the first to attempt to observe whether objectively 
and subjectively measured sleep interactions with next day functioning in relation to 
mood, dissociation and seizure frequency. This study was able to show that people 
with NES are likely to experience significantly more impaired sleep and subjectively 
report worse sleep quality than the general public. These outcomes are clinically 
relevant and contributes to our knowledge about features of NES. Additionally, I 
excluded people with a dual diagnosis of NES and ES, anyone with a history of a 
brain injury and known sleep disorders and have therefore attempted to account for 
circumstances known to cause sleep disturbances.  
 
Moreover, the results show that there were no significant differences in the 
misperception of sleep across the two groups despite suggestions that people with 
NES are likely to over-report their difficulties.  The results were further able to 
characterise the objective sleep profile of NES to encompass poorer sleep efficiency 
caused by wakefulness throughout sleep and frequency of awakenings as opposed to 
sleep duration, similar to those with depression. Furthermore, we found an 
indication that there could be a relationship between the number of awakenings 
during the preceding night on seizure frequency the following day, a finding worth 
further exploration by studies with larger samples. Finally, our study was conducted 
at a time when sleep in NES had started to gain interest, therefore, hope it will 







5.6.2. Limitations  
Irrespective of the results showing statically significant differences in the 
experiences of sleep between the two groups, our samples were small, unequal and 
we were unable to seek additional data to make up for data lost due to errors. I had 
to reduce our sample sizes due to unforeseeable loss of funding and additionally, due 
to drop-outs we did not meet our NES sample size. Therefore, our reduced sample 
size may have meant that the  multi-level modelling was underpowered and that I 
was unable to explore associations between sleep, mood and dissociation and seizure 
frequency.  
 
Moreover, our NES group reported more dissociation and poorer mood when 
measured at baseline and when measured daily across six days. As dissociation and 
mood have extensively been linked to impaired sleep, this is likely to have 
influenced our subjective and objective sleep outcomes for our NES group. 
Similarly, our sleep outcomes may have also been influenced by factors I did not 
take into account such seasonal changes, whether participants were undergoing 
psychotherapy and the use of anti-depressants. Finally, while actigraphy is 
considered an effective way to collect objective sleep data, it is less effective than 
PSG when recording large amounts of WASO like those recorded in the NES 
sample in our study. Therefore, while this study adds to our understanding of sleep 






5.7. Clinical implication 
There is an increasing interest in sleep within NES, and we hope that our outcomes 
contribute to this. Our results suggest that poor sleep is an objective and subjective 
problem in NES, rather than a misinterpretation of sleep experienced. We, therefore, 
hope it will encourage clinicians to inquire about sleep routinely. Given that sleep 
impairment is present and is an important indicator of overall wellbeing across 
populations, sleep interventions such as CBTI-I could be considered for those with 
NES who report impaired sleeping. Additionally, trails for CBTI-I to improve sleep 
in NES in order to improve overall wellbeing may now be warranted.  However, our 
data was too underpowered to detect the impact of poor sleep in next day seizures; 
we are therefore unable to suggest whether sleep interventions will improve seizure 
severity in NES.  
 
5.8. Research recommendation 
This study shows promising outcomes indicating that sleep is an important factor in 
the experience of NES and suggests a profile for sleep impairment in NES of 
excessive nocturnal wakefulness and awakenings. However, the limitations with our 
study suggest that there are several aspects that future research may focus on to both 
expand this field of research and to address the limitations we came across. Firstly, I 
recommend that future studies further explore the experiences of sleep in NES using 
larger samples from an NES population in settings beyond psychotherapy services 
as this is likely to have impacted our outcomes. Secondly I suggest that if such 
research includes a control sample that that is data collected alongside the NES data 






would well do adopt a longitudinal design in order to explore whether impaired 
sleep leads to poorer next day functioning and higher seizure frequency. Finally, as 
the research in this field grows, I hope that research will extend their focus into 
whether sleep interventions such as CBT-I might be useful in improving sleep and 
functioning in those with NES. 
 
5.9. Conclusion 
This prospective study exploring whether impaired sleep is a feature in NES 
demonstrates that those with NES are more likely to experience objectively poorer 
sleep efficiency, more extended periods of wakefulness and more awakenings. The 
outcomes further showed that those with NES did not have larger misperceptions of 
sleep than the control groups, as initially expected. Due to our small and 
underpowered sample, I was unable to show any associations between preceding 
night’s objective measures of impaired sleep and next day mood, dissociation and 
seizure frequency. However, I did find an indication that preceding night’s 
awakenings may be linked to seizure frequency the following day, which is worth 
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8.1.2. NHS to NHS Letter of Access 
 
CONFIRMATION OF PRE-ENGAGEMENT CHECKS 
 
Research Office 





Re: Researcher’s name: Saafi Mousa 
Job title: Trainee Clinical Psychologist 
Contract end-date: 30th September, 2019 
Workplace and postal address:  
Department of Clinical Psychology, Fielding House. St James’s University 
Hospital, Beckett Street, Leeds, LS9 7TF 
 
Electronic Staff Record number: 26192508 
 
As the representative of the NHS employer1 of the above-named person, I can 
confirm that s/he is employed by this organisation.  I understand that the 
responsibility for ensuring that the appropriate pre-engagement checks have 
been undertaken rests with us as the individual’s substantive employer. I can 
confirm that the appropriate pre-engagement checks have been completed, 
commensurate with her/his job description and proposed research role in your 
NHS organisation, and in line with NHS employment checks standards 
 
Name of employer’s representative: Dr Jan Hughes 
Job Title: Joint Programme Director 
Workplace address: 
Department of Clinical Psychology, Fielding House. St James’s University 
Hospital, Beckett Street, Leeds, LS9 7TF 
Tel: 0113 3432738 
Email: j.hughes@leeds.ac.uk 
                                            







8.1.3. School of Psychology, University of Leeds Approval  
 
From: Ethics <donotreply@leeds.ac.uk> 
Date: 18 September 2018 at 11:28:25 BST 
To: <H.Nash@leeds.ac.uk> 
Subject: Your ethics application has been passed. 
Reply-To: <donotreply@leeds.ac.uk> 
Dear Hannah Nash, 
Re your ethics application, The experiences of sleep, dissociation and mood in non-
epileptic seizures., ethics reference number: PSC-431. 
I am pleased to inform you that the above research application has been reviewed by 
the School of Psychology Research Ethics Committee and has been approved. 
  
If the reviewers have left any comments they will appear below. 
  
Primary reviewer comments (if applicable) Cristina Harney:  
  
Secondary reviewer comments (if applicable) :  
  
Please note that this approval only relates to the particular version of documentation 
supplied in this specific application (ethics ref no: PSC-431).  
  
If you wish to make any amendments to the approved documentation, please note 
that all changes require ethical approval prior to implementation. 
  
Please note: You are expected to keep a record of all your approved documentation, 
as well as documents such as sample consent forms, and other documents relating to 
the study. This should be kept in your study file, which should be readily available 
for audit purposes. 
  
You will be given a two-week notice period if your project is to be audited. There is 













8.2 Study Documents 
 
8.2.1. Letter of Invitation  
 
Letter of Invitation  
 
 
Dear Potential Participant,   
You are being invited to take part in a study about sleep in non-epileptic seizures 
(NES);  
“The experiences of sleep, dissociation and mood in non-epileptic seizures”. 
My name is Saafi Mousa and I am currently a Psychologist in Clinical Training at 
the University of Leeds. In order to complete my Clinical Psychology Doctorate 
Programme, all trainees are asked to complete a Thesis undertaking original 
clinically-important research. I am interested in sleep in NES.  
Ethical approval for this study has been sought from the NHS Research Ethics 
Committee (IRAS project number: 239312).  
 
Sometimes, people with NES report that they have difficulties sleeping and 
currently, we know little about the relationship between NES and sleep. Our study 
aims to investigate how people with NES sleep and whether this can affect how 
people feel the next day, in relation to seizures and mood. We hope our study will 
address the gap in our knowledge about NES and to use this knowledge to influence 
treatment options for people with NES. 
If you decide to take part, we ask that you consent to your clinician passing on your 
name and phone number to the researcher. If you partake, we would ask you to 
attend a half an hour pre-participation meeting in which you will be asked to 
complete questionnaires about your experiences of sleep, mood and dissociation. 
After this meeting, we will ask you to wear an activity monitor on your wrist for a 
week and to complete a sleep diary in the mornings and a short mood and 
dissociation questionnaire in the evening. After this week, we will ask you to come 









Please read the included Participant’s Information Sheet attached carefully. If 
you do not wish to take part, please return this letter and participation sheet to 
your clinician.  
 
However, if you are interested in taking part, or if you would like to find out more 
about the study, you do not have to do anything at this stage. If you do not return 
this letter and participation sheet to your clinician, they will ask if they can give your 
name and phone number to the researcher working on the study. The researcher will 
then contact you within the next four weeks to discuss the study. 
 
If you have any concerns about the study, please contact Dr Chris Graham, Clinical 
Psychologist and University Academic Fellow, or Mrs Clare Skinner, Head of 
Research Integrity and Governance:  
 
 
Dr Chris Graham                                                     Mrs Clare Skinner 
C.D.Graham@leeds.ac.uk |                                        Goverance-Ethics@leeds.ac.uk |  





















8.2.2. Participant’s Information Sheet 
 
Participant Information Sheet 
 
The experiences of Sleep, Dissociation and Mood in Non-Epileptic Seizures  
 
You are being invited to take part in this research project. This sheet tells you about 
why we are doing this study and what it will involve. It’s important that you 
understand the study before you decide to get involved.  
 
Who will be doing this project? 
Saafi Mousa, Trainee Clinical Psychologist at The University of Leeds will be doing 
this project. As part of the three-year training course all trainees are asked to 
complete a Thesis undertaking original research in order to complete the Clinical 
Psychology Doctorate Programme.  
 
What is the purpose of the project? 
There is little knowledge on what causes Non-Epileptic Seizures (NES), and 
currently there is no gold standard treatment for those with NES. Individuals with 
this condition often report sleep difficulties. However, to help us design future 
treatments we need more detailed knowledge about how people with NES 
experience sleep.  
 
In this study, we want to know about what sleep is like for people with NES and 
how it affects next day feelings. We hope to address the gap in our knowledge about 
NES and to use this knowledge to influence treatment options for people with NES.  
 
What will happen if I choose to take part? 
This study will involve two meetings that will take no longer than 30 minutes and a 
7-day period in which we will ask you wear an Actiwatch at home and complete 







You will be invited to a pre-participation meeting at your local hospital, where you 
usually meet with your healthcare team. In this meeting, Saafi will give you more 
information about the study.  This meeting will give you the opportunity to talk 
through any questions or worries you might. You will then be asked to provide 
written consent to participate.  
 
You will then be asked to complete questionnaires about your experiences of sleep, 
dissociation and mood.  
 
After this, we will show you how to use an activity watch that we will give you, and 
how to complete the daily sleep and mood diaries. You will also be given contact 
details of the researcher should you want to contact them with any questions or 
queries you may have in your time as a participant.  
 
You will be asked to meet again after 7 days to return the activity watch and the 
diaries you completed at home and to debrief about your participation in this study.
  
Do I have to take part? 
No. You might decide that you don’t want to take part– that’s okay. Not taking part 
will not have any impact on the care you receive from your healthcare team.  
 
What are the advantages and disadvantages of taking part? 
There are no direct benefits of taking part of this study. However, as there is 
relatively little information on how to treat NES and we hope that understanding 
sleep in NES will inform future new treatments.   
 
Taking part will take up some of your time. You will be asked to complete a sleep 
diary upon waking and a questionnaire asking about experiences of dissociation, 
mood and seizures at the end of the day. It may take you up to 10 minutes to 
complete these in the morning and up to 10 minutes in the evening. You will also be 
asked to wear an activity monitor on your wrists consistently for 7 days and you 







What will happen to the results? 
As part of training at The University of Leeds all Trainee Clinical Psychologists are 
required to write the results up in a written report. The information within the report 
might be used in other ways, for example at conferences, meetings, poster 
presentations and in academic journals. You won’t be identified in any report or 
publication. We also hope to feedback the results to all the departments from which 
we have recruited.  
 
Will my answers be kept confidential? 
Yes. All the data collected from the questionnaires will be saved to a secure 
University server that can only be accessed by Saafi Mousa. The only time we 
would have to share information outside of your healthcare team is if we felt that 
your safety or another person’s safety was at risk, but we would always try to talk to 
you about this first. 
 
What if I change my mind? 
Once you have completed the questionnaires, we are unable to withdraw your data 
as this is collected anonymously and is therefore not identifiable. If you decide to 
take part and change your mind afterwards you can contact the researcher and 
inform them of this.  
 
What happens next? 
You will be contacted by Saafi Mousa to see whether you are still interested in 
taking part of this study. If you decide that you would like to take part, Saafi will 
agree a date and time with you over the phone to come in for a pre-participation 
meeting at your local hospital.  
 
If you have any concerns about the study, please contact my university supervisor, 
Dr Chris Graham or the Faculty Research Ethics and Governance Administrator:  
 
Dr Chris Graham (Clinical Psychologist and Research Fellow at the University of 







Faculty Research and Governance Administrator 
FMUniethics@leeds.ac.uk | 0113 343 1642  
 
Data Protection Information 
 
The University of Leeds is the sponsor for this study based in the United Kingdom. 
We will be using information from you in order to undertake this study and will act 
as the data controller for this study. This means that we are responsible for looking 
after your information and using it properly. The University of Leeds will keep 
identifiable information about you for 3 years after the study has finished.  
 
Your rights to access change or move your information are limited, as we need to 
manage your information in specific ways in order for the research to be reliable and 
accurate. If you withdraw from the study, we will keep the information about you 
that we have already obtained. To safeguard your rights, we will use the minimum 
personally-identifiable information possible. You can find out more about how we 
use your information by contacting David Wardle, University Data Protection 
Officer on DPO@leeds.ac.uk.  
 
What happens to the data collected from me in this study? 
Your NHS organisation will collect information from you for this research study in 
accordance with our instructions. Your NHS organisation will use your name and 
contact details to contact you about the research study, and make sure that relevant 
information about the study is recorded for your care, and to oversee the quality of 
the study. Individuals from the University of Leeds and regulatory organisations 
may look at your medical and research records to check the accuracy of the research 
study. Your local NHS organisation will pass these details to the University of Leeds 
along with the information collected from you. The only people in the University of 
Leeds who will have access to information that identifies you will be people who 
need to contact you for data collection meetings if you have indicated that you are 
interested in taking part in this research. The people who analyse the information 
will not be able to identify your data and will not be able to find out your name, 







Your local NHS organisation will keep identifiable information about you from this 
study for 3 years after the study has finished.  
 
When you agree to take part in a research study, the information about your health 
and care may be provided to researchers running other research studies in this 
organisation and in other organisations. These organisations may be universities, 
NHS organisations or companies involved in health and care research in this country 
or abroad. Your information will only be used by organisations and researchers to 
conduct research in accordance with the UK Policy Framework for Health and 
Social Care Research. 
 
The information collected for this study will not identify you and will not be 
combined with other information in a way that could identify you. The information 
will only be used for the purpose of health and care research, and cannot be used to 
contact you or to affect your care. It will not be used to make decisions about future 






























































































































































































































































































































































8.4. Analysis Output 
 
































































8.4.3. Multi-Level Modelling Output 
 
































































8.4.3.3. Impact of Sleep on NA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
